BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1206663 CC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35N3O4/c1-21-29-27-15-9-14-25-26(16-10-20-40-28-17-8-12-23-11-4-5-13-24(23)28)32(33(37)38)36(31(25)27)18-6-7-19-39-22(2)30(29)34-35(21)3/h4-5,8-9,11-15,17,22H,6-7,10,16,18-20H2,1-3H3,(H,37,38) GSHPRFUNVKYWPO-UHFFFAOYSA-N 571437 (rac)-2,3,15-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 1::US11440923, Example 2::US11440923, Example 3 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.20 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571437&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591936 473132600 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206664 CC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35N3O4/c1-21-29-27-15-9-14-25-26(16-10-20-40-28-17-8-12-23-11-4-5-13-24(23)28)32(33(37)38)36(31(25)27)18-6-7-19-39-22(2)30(29)34-35(21)3/h4-5,8-9,11-15,17,22H,6-7,10,16,18-20H2,1-3H3,(H,37,38) GSHPRFUNVKYWPO-UHFFFAOYSA-N 571437 (rac)-2,3,15-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 1::US11440923, Example 2::US11440923, Example 3 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571437&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591936 473132600 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206665 CC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35N3O4/c1-21-29-27-15-9-14-25-26(16-10-20-40-28-17-8-12-23-11-4-5-13-24(23)28)32(33(37)38)36(31(25)27)18-6-7-19-39-22(2)30(29)34-35(21)3/h4-5,8-9,11-15,17,22H,6-7,10,16,18-20H2,1-3H3,(H,37,38) GSHPRFUNVKYWPO-UHFFFAOYSA-N 571437 (rac)-2,3,15-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 1::US11440923, Example 2::US11440923, Example 3 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571437&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591936 473132600 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206666 CC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35N3O4/c1-21-29-27-15-9-14-25-26(16-10-20-40-28-17-8-12-23-11-4-5-13-24(23)28)32(33(37)38)36(31(25)27)18-6-7-19-39-22(2)30(29)34-35(21)3/h4-5,8-9,11-15,17,22H,6-7,10,16,18-20H2,1-3H3,(H,37,38) GSHPRFUNVKYWPO-UHFFFAOYSA-N 571437 (rac)-2,3,15-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 1::US11440923, Example 2::US11440923, Example 3 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571437&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591936 473132600 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206667 CC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35N3O4/c1-21-29-27-15-9-14-25-26(16-10-20-40-28-17-8-12-23-11-4-5-13-24(23)28)32(33(37)38)36(31(25)27)18-6-7-19-39-22(2)30(29)34-35(21)3/h4-5,8-9,11-15,17,22H,6-7,10,16,18-20H2,1-3H3,(H,37,38) GSHPRFUNVKYWPO-UHFFFAOYSA-N 571437 (rac)-2,3,15-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 1::US11440923, Example 2::US11440923, Example 3 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571437&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591936 473132600 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206668 CC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35N3O4/c1-21-29-27-15-9-14-25-26(16-10-20-40-28-17-8-12-23-11-4-5-13-24(23)28)32(33(37)38)36(31(25)27)18-6-7-19-39-22(2)30(29)34-35(21)3/h4-5,8-9,11-15,17,22H,6-7,10,16,18-20H2,1-3H3,(H,37,38) GSHPRFUNVKYWPO-UHFFFAOYSA-N 571437 (rac)-2,3,15-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 1::US11440923, Example 2::US11440923, Example 3 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571437&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591936 473132600 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206669 CC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35N3O4/c1-21-29-27-15-9-14-25-26(16-10-20-40-28-17-8-12-23-11-4-5-13-24(23)28)32(33(37)38)36(31(25)27)18-6-7-19-39-22(2)30(29)34-35(21)3/h4-5,8-9,11-15,17,22H,6-7,10,16,18-20H2,1-3H3,(H,37,38) GSHPRFUNVKYWPO-UHFFFAOYSA-N 571437 (rac)-2,3,15-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 1::US11440923, Example 2::US11440923, Example 3 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 22.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571437&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591936 473132600 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206670 CC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35N3O4/c1-21-29-27-15-9-14-25-26(16-10-20-40-28-17-8-12-23-11-4-5-13-24(23)28)32(33(37)38)36(31(25)27)18-6-7-19-39-22(2)30(29)34-35(21)3/h4-5,8-9,11-15,17,22H,6-7,10,16,18-20H2,1-3H3,(H,37,38) GSHPRFUNVKYWPO-UHFFFAOYSA-N 571437 (rac)-2,3,15-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 1::US11440923, Example 2::US11440923, Example 3 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571437&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591936 473132600 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206671 CC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35N3O4/c1-21-29-27-15-9-14-25-26(16-10-20-40-28-17-8-12-23-11-4-5-13-24(23)28)32(33(37)38)36(31(25)27)18-6-7-19-39-22(2)30(29)34-35(21)3/h4-5,8-9,11-15,17,22H,6-7,10,16,18-20H2,1-3H3,(H,37,38) GSHPRFUNVKYWPO-UHFFFAOYSA-N 571437 (rac)-2,3,15-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 1::US11440923, Example 2::US11440923, Example 3 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571437&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591936 473132600 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206672 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc-2c13 InChI=1S/C38H44N4O5/c1-26-34-31-14-8-13-29-30(15-9-23-46-32-16-7-11-27-10-3-4-12-28(27)32)37(38(43)44)42(36(29)31)18-5-6-22-47-33(35(34)39-40(26)2)17-19-41-20-24-45-25-21-41/h3-4,7-8,10-14,16,33H,5-6,9,15,17-25H2,1-2H3,(H,43,44) XIDPTYAUKDEXAO-UHFFFAOYSA-N 571440 (rac)-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 4::US11440923, Example 5::US11440923, Example 6 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571440&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591921 473132601 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206673 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc-2c13 InChI=1S/C38H44N4O5/c1-26-34-31-14-8-13-29-30(15-9-23-46-32-16-7-11-27-10-3-4-12-28(27)32)37(38(43)44)42(36(29)31)18-5-6-22-47-33(35(34)39-40(26)2)17-19-41-20-24-45-25-21-41/h3-4,7-8,10-14,16,33H,5-6,9,15,17-25H2,1-2H3,(H,43,44) XIDPTYAUKDEXAO-UHFFFAOYSA-N 571440 (rac)-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 4::US11440923, Example 5::US11440923, Example 6 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571440&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591921 473132601 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206674 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc-2c13 InChI=1S/C38H44N4O5/c1-26-34-31-14-8-13-29-30(15-9-23-46-32-16-7-11-27-10-3-4-12-28(27)32)37(38(43)44)42(36(29)31)18-5-6-22-47-33(35(34)39-40(26)2)17-19-41-20-24-45-25-21-41/h3-4,7-8,10-14,16,33H,5-6,9,15,17-25H2,1-2H3,(H,43,44) XIDPTYAUKDEXAO-UHFFFAOYSA-N 571440 (rac)-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 4::US11440923, Example 5::US11440923, Example 6 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 51.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571440&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591921 473132601 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206675 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc-2c13 InChI=1S/C38H44N4O5/c1-26-34-31-14-8-13-29-30(15-9-23-46-32-16-7-11-27-10-3-4-12-28(27)32)37(38(43)44)42(36(29)31)18-5-6-22-47-33(35(34)39-40(26)2)17-19-41-20-24-45-25-21-41/h3-4,7-8,10-14,16,33H,5-6,9,15,17-25H2,1-2H3,(H,43,44) XIDPTYAUKDEXAO-UHFFFAOYSA-N 571440 (rac)-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 4::US11440923, Example 5::US11440923, Example 6 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571440&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591921 473132601 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206676 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc-2c13 InChI=1S/C38H44N4O5/c1-26-34-31-14-8-13-29-30(15-9-23-46-32-16-7-11-27-10-3-4-12-28(27)32)37(38(43)44)42(36(29)31)18-5-6-22-47-33(35(34)39-40(26)2)17-19-41-20-24-45-25-21-41/h3-4,7-8,10-14,16,33H,5-6,9,15,17-25H2,1-2H3,(H,43,44) XIDPTYAUKDEXAO-UHFFFAOYSA-N 571440 (rac)-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers)::US11440923, Example 4::US11440923, Example 5::US11440923, Example 6 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571440&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591921 473132601 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206677 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C38H43FN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) RDZMVGOZFDLRGC-UHFFFAOYSA-N 571443 (rac)-4-fluoro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 7::US11440923, Example 8::US11440923, Example 9 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.660 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571443&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591860 473132602 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206678 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C38H43FN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) RDZMVGOZFDLRGC-UHFFFAOYSA-N 571443 (rac)-4-fluoro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 7::US11440923, Example 8::US11440923, Example 9 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571443&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591860 473132602 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206679 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C38H43FN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) RDZMVGOZFDLRGC-UHFFFAOYSA-N 571443 (rac)-4-fluoro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 7::US11440923, Example 8::US11440923, Example 9 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571443&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591860 473132602 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206680 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C38H43FN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) RDZMVGOZFDLRGC-UHFFFAOYSA-N 571443 (rac)-4-fluoro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 7::US11440923, Example 8::US11440923, Example 9 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.570 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571443&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591860 473132602 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206681 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C38H43FN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) RDZMVGOZFDLRGC-UHFFFAOYSA-N 571443 (rac)-4-fluoro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 7::US11440923, Example 8::US11440923, Example 9 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 58.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571443&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591860 473132602 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206682 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C38H43FN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) RDZMVGOZFDLRGC-UHFFFAOYSA-N 571443 (rac)-4-fluoro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 7::US11440923, Example 8::US11440923, Example 9 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571443&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591860 473132602 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206683 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C38H43FN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) RDZMVGOZFDLRGC-UHFFFAOYSA-N 571443 (rac)-4-fluoro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 7::US11440923, Example 8::US11440923, Example 9 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571443&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591860 473132602 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206684 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C39H45FN4O5/c1-3-31-35-34-30(40)16-15-29-28(13-9-23-48-32-14-8-11-26-10-4-5-12-27(26)32)38(39(45)46)44(37(29)34)18-6-7-22-49-33(36(35)41-42(31)2)17-19-43-20-24-47-25-21-43/h4-5,8,10-12,14-16,33H,3,6-7,9,13,17-25H2,1-2H3,(H,45,46) AISBLTHXOXGMSY-UHFFFAOYSA-N 571446 (rac)-3-ethyl-4-fluoro-2-methyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 10::US11440923, Example 11::US11440923, Example 12 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.720 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571446&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591905 473132603 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206685 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C39H45FN4O5/c1-3-31-35-34-30(40)16-15-29-28(13-9-23-48-32-14-8-11-26-10-4-5-12-27(26)32)38(39(45)46)44(37(29)34)18-6-7-22-49-33(36(35)41-42(31)2)17-19-43-20-24-47-25-21-43/h4-5,8,10-12,14-16,33H,3,6-7,9,13,17-25H2,1-2H3,(H,45,46) AISBLTHXOXGMSY-UHFFFAOYSA-N 571446 (rac)-3-ethyl-4-fluoro-2-methyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 10::US11440923, Example 11::US11440923, Example 12 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571446&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591905 473132603 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206686 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C39H45FN4O5/c1-3-31-35-34-30(40)16-15-29-28(13-9-23-48-32-14-8-11-26-10-4-5-12-27(26)32)38(39(45)46)44(37(29)34)18-6-7-22-49-33(36(35)41-42(31)2)17-19-43-20-24-47-25-21-43/h4-5,8,10-12,14-16,33H,3,6-7,9,13,17-25H2,1-2H3,(H,45,46) AISBLTHXOXGMSY-UHFFFAOYSA-N 571446 (rac)-3-ethyl-4-fluoro-2-methyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 10::US11440923, Example 11::US11440923, Example 12 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571446&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591905 473132603 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206687 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C39H45FN4O5/c1-3-31-35-34-30(40)16-15-29-28(13-9-23-48-32-14-8-11-26-10-4-5-12-27(26)32)38(39(45)46)44(37(29)34)18-6-7-22-49-33(36(35)41-42(31)2)17-19-43-20-24-47-25-21-43/h4-5,8,10-12,14-16,33H,3,6-7,9,13,17-25H2,1-2H3,(H,45,46) AISBLTHXOXGMSY-UHFFFAOYSA-N 571446 (rac)-3-ethyl-4-fluoro-2-methyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 10::US11440923, Example 11::US11440923, Example 12 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.540 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571446&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591905 473132603 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206688 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C39H45FN4O5/c1-3-31-35-34-30(40)16-15-29-28(13-9-23-48-32-14-8-11-26-10-4-5-12-27(26)32)38(39(45)46)44(37(29)34)18-6-7-22-49-33(36(35)41-42(31)2)17-19-43-20-24-47-25-21-43/h4-5,8,10-12,14-16,33H,3,6-7,9,13,17-25H2,1-2H3,(H,45,46) AISBLTHXOXGMSY-UHFFFAOYSA-N 571446 (rac)-3-ethyl-4-fluoro-2-methyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 10::US11440923, Example 11::US11440923, Example 12 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 40.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571446&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591905 473132603 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206689 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C39H45FN4O5/c1-3-31-35-34-30(40)16-15-29-28(13-9-23-48-32-14-8-11-26-10-4-5-12-27(26)32)38(39(45)46)44(37(29)34)18-6-7-22-49-33(36(35)41-42(31)2)17-19-43-20-24-47-25-21-43/h4-5,8,10-12,14-16,33H,3,6-7,9,13,17-25H2,1-2H3,(H,45,46) AISBLTHXOXGMSY-UHFFFAOYSA-N 571446 (rac)-3-ethyl-4-fluoro-2-methyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 10::US11440923, Example 11::US11440923, Example 12 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571446&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591905 473132603 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206690 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(F)c-2c13 InChI=1S/C39H45FN4O5/c1-3-31-35-34-30(40)16-15-29-28(13-9-23-48-32-14-8-11-26-10-4-5-12-27(26)32)38(39(45)46)44(37(29)34)18-6-7-22-49-33(36(35)41-42(31)2)17-19-43-20-24-47-25-21-43/h4-5,8,10-12,14-16,33H,3,6-7,9,13,17-25H2,1-2H3,(H,45,46) AISBLTHXOXGMSY-UHFFFAOYSA-N 571446 (rac)-3-ethyl-4-fluoro-2-methyl-15-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 10::US11440923, Example 11::US11440923, Example 12 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571446&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591905 473132603 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206691 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) UMIMWGJEBPFPIS-UHFFFAOYSA-N 571449 (rac)-4-chloro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 13::US11440923, Example 14::US11440923, Example 15 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.60 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571449&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591949 473132604 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206692 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) UMIMWGJEBPFPIS-UHFFFAOYSA-N 571449 (rac)-4-chloro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 13::US11440923, Example 14::US11440923, Example 15 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571449&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591949 473132604 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206693 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) UMIMWGJEBPFPIS-UHFFFAOYSA-N 571449 (rac)-4-chloro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 13::US11440923, Example 14::US11440923, Example 15 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571449&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591949 473132604 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206694 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) UMIMWGJEBPFPIS-UHFFFAOYSA-N 571449 (rac)-4-chloro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 13::US11440923, Example 14::US11440923, Example 15 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.530 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571449&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591949 473132604 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206695 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) UMIMWGJEBPFPIS-UHFFFAOYSA-N 571449 (rac)-4-chloro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 13::US11440923, Example 14::US11440923, Example 15 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571449&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591949 473132604 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206696 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) UMIMWGJEBPFPIS-UHFFFAOYSA-N 571449 (rac)-4-chloro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 13::US11440923, Example 14::US11440923, Example 15 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571449&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591949 473132604 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206697 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) UMIMWGJEBPFPIS-UHFFFAOYSA-N 571449 (rac)-4-chloro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 13::US11440923, Example 14::US11440923, Example 15 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 65.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571449&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591949 473132604 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206698 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) UMIMWGJEBPFPIS-UHFFFAOYSA-N 571449 (rac)-4-chloro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 13::US11440923, Example 14::US11440923, Example 15 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571449&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591949 473132604 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206699 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClN4O5/c1-25-33-34-30(39)15-14-29-28(12-8-22-47-31-13-7-10-26-9-3-4-11-27(26)31)37(38(44)45)43(36(29)34)17-5-6-21-48-32(35(33)40-41(25)2)16-18-42-19-23-46-24-20-42/h3-4,7,9-11,13-15,32H,5-6,8,12,16-24H2,1-2H3,(H,44,45) UMIMWGJEBPFPIS-UHFFFAOYSA-N 571449 (rac)-4-chloro-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 13::US11440923, Example 14::US11440923, Example 15 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571449&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591949 473132604 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206700 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H42ClFN4O5/c1-24-33-34-30(39)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(40)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) CJILTEZPSOPNKJ-UHFFFAOYSA-N 571452 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 16::US11440923, Example 17::US11440923, Example 18 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.00 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571452&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591796 473132605 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206701 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H42ClFN4O5/c1-24-33-34-30(39)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(40)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) CJILTEZPSOPNKJ-UHFFFAOYSA-N 571452 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 16::US11440923, Example 17::US11440923, Example 18 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571452&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591796 473132605 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206702 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H42ClFN4O5/c1-24-33-34-30(39)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(40)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) CJILTEZPSOPNKJ-UHFFFAOYSA-N 571452 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 16::US11440923, Example 17::US11440923, Example 18 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571452&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591796 473132605 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206703 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H42ClFN4O5/c1-24-33-34-30(39)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(40)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) CJILTEZPSOPNKJ-UHFFFAOYSA-N 571452 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 16::US11440923, Example 17::US11440923, Example 18 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571452&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591796 473132605 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206704 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H42ClFN4O5/c1-24-33-34-30(39)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(40)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) CJILTEZPSOPNKJ-UHFFFAOYSA-N 571452 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 16::US11440923, Example 17::US11440923, Example 18 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571452&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591796 473132605 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206705 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H42ClFN4O5/c1-24-33-34-30(39)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(40)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) CJILTEZPSOPNKJ-UHFFFAOYSA-N 571452 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 16::US11440923, Example 17::US11440923, Example 18 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571452&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591796 473132605 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206706 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H42ClFN4O5/c1-24-33-34-30(39)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(40)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) CJILTEZPSOPNKJ-UHFFFAOYSA-N 571452 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 16::US11440923, Example 17::US11440923, Example 18 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 42.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571452&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591796 473132605 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206707 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H42ClFN4O5/c1-24-33-34-30(39)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(40)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) CJILTEZPSOPNKJ-UHFFFAOYSA-N 571452 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 16::US11440923, Example 17::US11440923, Example 18 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571452&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591796 473132605 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206708 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H42ClFN4O5/c1-24-33-34-30(39)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(40)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) CJILTEZPSOPNKJ-UHFFFAOYSA-N 571452 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 16::US11440923, Example 17::US11440923, Example 18 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571452&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591796 473132605 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206709 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C38H42F2N4O5/c1-24-33-34-30(40)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(39)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) LGBQURTUDABKTP-UHFFFAOYSA-N 571455 (rac)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 19::US11440923, Example 20::US11440923, Example 21 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.60 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571455&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591870 473132606 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206710 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C38H42F2N4O5/c1-24-33-34-30(40)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(39)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) LGBQURTUDABKTP-UHFFFAOYSA-N 571455 (rac)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 19::US11440923, Example 20::US11440923, Example 21 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571455&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591870 473132606 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206711 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C38H42F2N4O5/c1-24-33-34-30(40)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(39)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) LGBQURTUDABKTP-UHFFFAOYSA-N 571455 (rac)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 19::US11440923, Example 20::US11440923, Example 21 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571455&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591870 473132606 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206712 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C38H42F2N4O5/c1-24-33-34-30(40)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(39)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) LGBQURTUDABKTP-UHFFFAOYSA-N 571455 (rac)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 19::US11440923, Example 20::US11440923, Example 21 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.790 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571455&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591870 473132606 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206713 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C38H42F2N4O5/c1-24-33-34-30(40)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(39)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) LGBQURTUDABKTP-UHFFFAOYSA-N 571455 (rac)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 19::US11440923, Example 20::US11440923, Example 21 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571455&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591870 473132606 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206714 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C38H42F2N4O5/c1-24-33-34-30(40)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(39)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) LGBQURTUDABKTP-UHFFFAOYSA-N 571455 (rac)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 19::US11440923, Example 20::US11440923, Example 21 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571455&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591870 473132606 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206715 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C38H42F2N4O5/c1-24-33-34-30(40)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(39)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) LGBQURTUDABKTP-UHFFFAOYSA-N 571455 (rac)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 19::US11440923, Example 20::US11440923, Example 21 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 160 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571455&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591870 473132606 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206716 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C38H42F2N4O5/c1-24-33-34-30(40)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(39)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) LGBQURTUDABKTP-UHFFFAOYSA-N 571455 (rac)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 19::US11440923, Example 20::US11440923, Example 21 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571455&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591870 473132606 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206717 Cc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C38H42F2N4O5/c1-24-33-34-30(40)13-12-29-28(8-6-20-48-31-9-5-7-25-23-26(39)10-11-27(25)31)37(38(45)46)44(36(29)34)15-3-4-19-49-32(35(33)41-42(24)2)14-16-43-17-21-47-22-18-43/h5,7,9-13,23,32H,3-4,6,8,14-22H2,1-2H3,(H,45,46) LGBQURTUDABKTP-UHFFFAOYSA-N 571455 (rac)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 19::US11440923, Example 20::US11440923, Example 21 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571455&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591870 473132606 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206718 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) RQXSLNDYCDRXAC-UHFFFAOYSA-N 571458 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 22 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571458&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591896 473132607 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206719 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) RQXSLNDYCDRXAC-UHFFFAOYSA-N 571458 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 22 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571458&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591896 473132607 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206720 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) RQXSLNDYCDRXAC-UHFFFAOYSA-N 571458 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 22 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571458&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591896 473132607 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206721 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) RQXSLNDYCDRXAC-UHFFFAOYSA-N 571459 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine (Enantiomer 1)::US11440923, Example 23 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.630 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571459&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591896 473132608 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206722 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) RQXSLNDYCDRXAC-UHFFFAOYSA-N 571459 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine (Enantiomer 1)::US11440923, Example 23 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571459&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591896 473132608 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206723 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) RQXSLNDYCDRXAC-UHFFFAOYSA-N 571459 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine (Enantiomer 1)::US11440923, Example 23 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571459&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591896 473132608 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206724 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) RQXSLNDYCDRXAC-UHFFFAOYSA-N 571460 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—N-ethylethanamine (Enantiomer 2)::US11440923, Example 24 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 28.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571460&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591896 473132609 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206725 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) RQXSLNDYCDRXAC-UHFFFAOYSA-N 571460 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—N-ethylethanamine (Enantiomer 2)::US11440923, Example 24 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571460&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591896 473132609 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206726 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) RQXSLNDYCDRXAC-UHFFFAOYSA-N 571460 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—N-ethylethanamine (Enantiomer 2)::US11440923, Example 24 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571460&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591896 473132609 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206727 CCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C34H36ClN3O4/c1-4-27-31-29(21(2)37(3)36-31)30-26(35)17-16-25-24(33(34(39)40)38(32(25)30)18-7-8-19-41-27)14-10-20-42-28-15-9-12-22-11-5-6-13-23(22)28/h5-6,9,11-13,15-17,27H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) SRCCZISYAVXKLD-UHFFFAOYSA-N 571461 (rac)-4-chloro-15-ethyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 25 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.90 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571461&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591850 473132610 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206728 CCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C34H36ClN3O4/c1-4-27-31-29(21(2)37(3)36-31)30-26(35)17-16-25-24(33(34(39)40)38(32(25)30)18-7-8-19-41-27)14-10-20-42-28-15-9-12-22-11-5-6-13-23(22)28/h5-6,9,11-13,15-17,27H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) SRCCZISYAVXKLD-UHFFFAOYSA-N 571461 (rac)-4-chloro-15-ethyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 25 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571461&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591850 473132610 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206729 CCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C34H36ClN3O4/c1-4-27-31-29(21(2)37(3)36-31)30-26(35)17-16-25-24(33(34(39)40)38(32(25)30)18-7-8-19-41-27)14-10-20-42-28-15-9-12-22-11-5-6-13-23(22)28/h5-6,9,11-13,15-17,27H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) SRCCZISYAVXKLD-UHFFFAOYSA-N 571461 (rac)-4-chloro-15-ethyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 25 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571461&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591850 473132610 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206730 Cc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClN3O5/c1-21-29-30-26(35)15-14-25-24(12-8-20-42-27-13-7-10-22-9-3-4-11-23(22)27)33(34(40)41)38(32(25)30)17-5-6-19-43-28(16-18-39)31(29)36-37(21)2/h3-4,7,9-11,13-15,28,39H,5-6,8,12,16-20H2,1-2H3,(H,40,41) BEVCGKXTXMHMFO-UHFFFAOYSA-N 571462 (rac)-4-chloro-15-(2-hydroxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 26 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571462&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591807 473132611 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206731 Cc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClN3O5/c1-21-29-30-26(35)15-14-25-24(12-8-20-42-27-13-7-10-22-9-3-4-11-23(22)27)33(34(40)41)38(32(25)30)17-5-6-19-43-28(16-18-39)31(29)36-37(21)2/h3-4,7,9-11,13-15,28,39H,5-6,8,12,16-20H2,1-2H3,(H,40,41) BEVCGKXTXMHMFO-UHFFFAOYSA-N 571462 (rac)-4-chloro-15-(2-hydroxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 26 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571462&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591807 473132611 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206732 Cc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClN3O5/c1-21-29-30-26(35)15-14-25-24(12-8-20-42-27-13-7-10-22-9-3-4-11-23(22)27)33(34(40)41)38(32(25)30)17-5-6-19-43-28(16-18-39)31(29)36-37(21)2/h3-4,7,9-11,13-15,28,39H,5-6,8,12,16-20H2,1-2H3,(H,40,41) BEVCGKXTXMHMFO-UHFFFAOYSA-N 571462 (rac)-4-chloro-15-(2-hydroxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 26 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571462&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591807 473132611 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206733 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C(F)(F)F InChI=1S/C34H33ClF3N3O4/c1-3-25-28-27-24(35)16-15-23-22(13-9-19-44-26-14-8-11-20-10-4-5-12-21(20)26)31(33(42)43)41(30(23)27)17-6-7-18-45-32(34(36,37)38)29(28)39-40(25)2/h4-5,8,10-12,14-16,32H,3,6-7,9,13,17-19H2,1-2H3,(H,42,43) LFBYVLSJEJBMEJ-UHFFFAOYSA-N 571463 (rac)-4-Chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-15-(trifluoromethyl)-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 27 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.80 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571463&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591925 473132612 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206734 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C(F)(F)F InChI=1S/C34H33ClF3N3O4/c1-3-25-28-27-24(35)16-15-23-22(13-9-19-44-26-14-8-11-20-10-4-5-12-21(20)26)31(33(42)43)41(30(23)27)17-6-7-18-45-32(34(36,37)38)29(28)39-40(25)2/h4-5,8,10-12,14-16,32H,3,6-7,9,13,17-19H2,1-2H3,(H,42,43) LFBYVLSJEJBMEJ-UHFFFAOYSA-N 571463 (rac)-4-Chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-15-(trifluoromethyl)-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 27 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 18600 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571463&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591925 473132612 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206735 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C(F)(F)F InChI=1S/C34H33ClF3N3O4/c1-3-25-28-27-24(35)16-15-23-22(13-9-19-44-26-14-8-11-20-10-4-5-12-21(20)26)31(33(42)43)41(30(23)27)17-6-7-18-45-32(34(36,37)38)29(28)39-40(25)2/h4-5,8,10-12,14-16,32H,3,6-7,9,13,17-19H2,1-2H3,(H,42,43) LFBYVLSJEJBMEJ-UHFFFAOYSA-N 571463 (rac)-4-Chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-15-(trifluoromethyl)-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 27 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571463&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591925 473132612 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206736 Cc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C35H36ClN3O4/c1-21-29-30-27(36)17-16-26-25(12-8-20-42-28-13-7-10-22-9-3-4-11-24(22)28)33(35(40)41)39(32(26)30)18-5-6-19-43-34(23-14-15-23)31(29)37-38(21)2/h3-4,7,9-11,13,16-17,23,34H,5-6,8,12,14-15,18-20H2,1-2H3,(H,40,41) ZYTWBPWAQMGSAQ-UHFFFAOYSA-N 571464 (rac)-4-Chloro-15-cyclopropyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 28 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571464&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591928 473132613 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206737 Cc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C35H36ClN3O4/c1-21-29-30-27(36)17-16-26-25(12-8-20-42-28-13-7-10-22-9-3-4-11-24(22)28)33(35(40)41)39(32(26)30)18-5-6-19-43-34(23-14-15-23)31(29)37-38(21)2/h3-4,7,9-11,13,16-17,23,34H,5-6,8,12,14-15,18-20H2,1-2H3,(H,40,41) ZYTWBPWAQMGSAQ-UHFFFAOYSA-N 571464 (rac)-4-Chloro-15-cyclopropyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 28 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571464&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591928 473132613 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206738 Cc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C35H36ClN3O4/c1-21-29-30-27(36)17-16-26-25(12-8-20-42-28-13-7-10-22-9-3-4-11-24(22)28)33(35(40)41)39(32(26)30)18-5-6-19-43-34(23-14-15-23)31(29)37-38(21)2/h3-4,7,9-11,13,16-17,23,34H,5-6,8,12,14-15,18-20H2,1-2H3,(H,40,41) ZYTWBPWAQMGSAQ-UHFFFAOYSA-N 571464 (rac)-4-Chloro-15-cyclopropyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 28 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 19800 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571464&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591928 473132613 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206739 CCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C34H36ClN3O4/c1-4-27-31-29(21(2)37(3)36-31)30-26(35)17-16-25-24(33(34(39)40)38(32(25)30)18-7-8-19-41-27)14-10-20-42-28-15-9-12-22-11-5-6-13-23(22)28/h5-6,9,11-13,15-17,27H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) SRCCZISYAVXKLD-UHFFFAOYSA-N 571465 (+)-4-chloro-15-ethyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 29 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.00 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571465&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591850 473132614 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206740 CCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C34H36ClN3O4/c1-4-27-31-29(21(2)37(3)36-31)30-26(35)17-16-25-24(33(34(39)40)38(32(25)30)18-7-8-19-41-27)14-10-20-42-28-15-9-12-22-11-5-6-13-23(22)28/h5-6,9,11-13,15-17,27H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) SRCCZISYAVXKLD-UHFFFAOYSA-N 571465 (+)-4-chloro-15-ethyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 29 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571465&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591850 473132614 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206741 CCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C34H36ClN3O4/c1-4-27-31-29(21(2)37(3)36-31)30-26(35)17-16-25-24(33(34(39)40)38(32(25)30)18-7-8-19-41-27)14-10-20-42-28-15-9-12-22-11-5-6-13-23(22)28/h5-6,9,11-13,15-17,27H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) SRCCZISYAVXKLD-UHFFFAOYSA-N 571465 (+)-4-chloro-15-ethyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 29 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 14200 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571465&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591850 473132614 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206742 CCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C34H36ClN3O4/c1-4-27-31-29(21(2)37(3)36-31)30-26(35)17-16-25-24(33(34(39)40)38(32(25)30)18-7-8-19-41-27)14-10-20-42-28-15-9-12-22-11-5-6-13-23(22)28/h5-6,9,11-13,15-17,27H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) SRCCZISYAVXKLD-UHFFFAOYSA-N 571466 (−)-4-chloro-15-ethyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 30 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 200 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571466&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591850 473132615 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206743 CCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C34H36ClN3O4/c1-4-27-31-29(21(2)37(3)36-31)30-26(35)17-16-25-24(33(34(39)40)38(32(25)30)18-7-8-19-41-27)14-10-20-42-28-15-9-12-22-11-5-6-13-23(22)28/h5-6,9,11-13,15-17,27H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) SRCCZISYAVXKLD-UHFFFAOYSA-N 571466 (−)-4-chloro-15-ethyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 30 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571466&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591850 473132615 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206744 CCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C34H36ClN3O4/c1-4-27-31-29(21(2)37(3)36-31)30-26(35)17-16-25-24(33(34(39)40)38(32(25)30)18-7-8-19-41-27)14-10-20-42-28-15-9-12-22-11-5-6-13-23(22)28/h5-6,9,11-13,15-17,27H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) SRCCZISYAVXKLD-UHFFFAOYSA-N 571466 (−)-4-chloro-15-ethyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 30 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571466&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591850 473132615 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206745 Cc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClN3O5/c1-21-29-30-26(35)15-14-25-24(12-8-20-42-27-13-7-10-22-9-3-4-11-23(22)27)33(34(40)41)38(32(25)30)17-5-6-19-43-28(16-18-39)31(29)36-37(21)2/h3-4,7,9-11,13-15,28,39H,5-6,8,12,16-20H2,1-2H3,(H,40,41) BEVCGKXTXMHMFO-UHFFFAOYSA-N 571467 (+)-4-chloro-15-(2-hydroxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 31 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.260 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571467&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591807 473132616 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206746 Cc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClN3O5/c1-21-29-30-26(35)15-14-25-24(12-8-20-42-27-13-7-10-22-9-3-4-11-23(22)27)33(34(40)41)38(32(25)30)17-5-6-19-43-28(16-18-39)31(29)36-37(21)2/h3-4,7,9-11,13-15,28,39H,5-6,8,12,16-20H2,1-2H3,(H,40,41) BEVCGKXTXMHMFO-UHFFFAOYSA-N 571467 (+)-4-chloro-15-(2-hydroxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 31 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571467&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591807 473132616 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206747 Cc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClN3O5/c1-21-29-30-26(35)15-14-25-24(12-8-20-42-27-13-7-10-22-9-3-4-11-23(22)27)33(34(40)41)38(32(25)30)17-5-6-19-43-28(16-18-39)31(29)36-37(21)2/h3-4,7,9-11,13-15,28,39H,5-6,8,12,16-20H2,1-2H3,(H,40,41) BEVCGKXTXMHMFO-UHFFFAOYSA-N 571467 (+)-4-chloro-15-(2-hydroxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 31 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571467&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591807 473132616 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206748 Cc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClN3O5/c1-21-29-30-26(35)15-14-25-24(12-8-20-42-27-13-7-10-22-9-3-4-11-23(22)27)33(34(40)41)38(32(25)30)17-5-6-19-43-28(16-18-39)31(29)36-37(21)2/h3-4,7,9-11,13-15,28,39H,5-6,8,12,16-20H2,1-2H3,(H,40,41) BEVCGKXTXMHMFO-UHFFFAOYSA-N 571468 (−)-4-chloro-15-(2-hydroxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 32 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 75.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571468&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591807 473132617 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206749 Cc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClN3O5/c1-21-29-30-26(35)15-14-25-24(12-8-20-42-27-13-7-10-22-9-3-4-11-23(22)27)33(34(40)41)38(32(25)30)17-5-6-19-43-28(16-18-39)31(29)36-37(21)2/h3-4,7,9-11,13-15,28,39H,5-6,8,12,16-20H2,1-2H3,(H,40,41) BEVCGKXTXMHMFO-UHFFFAOYSA-N 571468 (−)-4-chloro-15-(2-hydroxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 32 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571468&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591807 473132617 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206750 Cc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClN3O5/c1-21-29-30-26(35)15-14-25-24(12-8-20-42-27-13-7-10-22-9-3-4-11-23(22)27)33(34(40)41)38(32(25)30)17-5-6-19-43-28(16-18-39)31(29)36-37(21)2/h3-4,7,9-11,13-15,28,39H,5-6,8,12,16-20H2,1-2H3,(H,40,41) BEVCGKXTXMHMFO-UHFFFAOYSA-N 571468 (−)-4-chloro-15-(2-hydroxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 32 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571468&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591807 473132617 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206751 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C(F)(F)F InChI=1S/C34H33ClF3N3O4/c1-3-25-28-27-24(35)16-15-23-22(13-9-19-44-26-14-8-11-20-10-4-5-12-21(20)26)31(33(42)43)41(30(23)27)17-6-7-18-45-32(34(36,37)38)29(28)39-40(25)2/h4-5,8,10-12,14-16,32H,3,6-7,9,13,17-19H2,1-2H3,(H,42,43) LFBYVLSJEJBMEJ-UHFFFAOYSA-N 571469 (+)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-15-(trifluoromethyl)-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 33 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.10 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571469&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591925 473132618 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206752 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C(F)(F)F InChI=1S/C34H33ClF3N3O4/c1-3-25-28-27-24(35)16-15-23-22(13-9-19-44-26-14-8-11-20-10-4-5-12-21(20)26)31(33(42)43)41(30(23)27)17-6-7-18-45-32(34(36,37)38)29(28)39-40(25)2/h4-5,8,10-12,14-16,32H,3,6-7,9,13,17-19H2,1-2H3,(H,42,43) LFBYVLSJEJBMEJ-UHFFFAOYSA-N 571469 (+)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-15-(trifluoromethyl)-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 33 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 16300 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571469&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591925 473132618 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206753 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C(F)(F)F InChI=1S/C34H33ClF3N3O4/c1-3-25-28-27-24(35)16-15-23-22(13-9-19-44-26-14-8-11-20-10-4-5-12-21(20)26)31(33(42)43)41(30(23)27)17-6-7-18-45-32(34(36,37)38)29(28)39-40(25)2/h4-5,8,10-12,14-16,32H,3,6-7,9,13,17-19H2,1-2H3,(H,42,43) LFBYVLSJEJBMEJ-UHFFFAOYSA-N 571469 (+)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-15-(trifluoromethyl)-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 33 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571469&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591925 473132618 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206754 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C(F)(F)F InChI=1S/C34H33ClF3N3O4/c1-3-25-28-27-24(35)16-15-23-22(13-9-19-44-26-14-8-11-20-10-4-5-12-21(20)26)31(33(42)43)41(30(23)27)17-6-7-18-45-32(34(36,37)38)29(28)39-40(25)2/h4-5,8,10-12,14-16,32H,3,6-7,9,13,17-19H2,1-2H3,(H,42,43) LFBYVLSJEJBMEJ-UHFFFAOYSA-N 571470 (−)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-15-(trifluoromethyl)-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 34 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 370 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571470&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591925 473132619 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206755 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C(F)(F)F InChI=1S/C34H33ClF3N3O4/c1-3-25-28-27-24(35)16-15-23-22(13-9-19-44-26-14-8-11-20-10-4-5-12-21(20)26)31(33(42)43)41(30(23)27)17-6-7-18-45-32(34(36,37)38)29(28)39-40(25)2/h4-5,8,10-12,14-16,32H,3,6-7,9,13,17-19H2,1-2H3,(H,42,43) LFBYVLSJEJBMEJ-UHFFFAOYSA-N 571470 (−)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-15-(trifluoromethyl)-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 34 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 17800 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571470&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591925 473132619 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206756 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C(F)(F)F InChI=1S/C34H33ClF3N3O4/c1-3-25-28-27-24(35)16-15-23-22(13-9-19-44-26-14-8-11-20-10-4-5-12-21(20)26)31(33(42)43)41(30(23)27)17-6-7-18-45-32(34(36,37)38)29(28)39-40(25)2/h4-5,8,10-12,14-16,32H,3,6-7,9,13,17-19H2,1-2H3,(H,42,43) LFBYVLSJEJBMEJ-UHFFFAOYSA-N 571470 (−)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-15-(trifluoromethyl)-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 34 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571470&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591925 473132619 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206757 Cc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C35H36ClN3O4/c1-21-29-30-27(36)17-16-26-25(12-8-20-42-28-13-7-10-22-9-3-4-11-24(22)28)33(35(40)41)39(32(26)30)18-5-6-19-43-34(23-14-15-23)31(29)37-38(21)2/h3-4,7,9-11,13,16-17,23,34H,5-6,8,12,14-15,18-20H2,1-2H3,(H,40,41) ZYTWBPWAQMGSAQ-UHFFFAOYSA-N 571471 (+)-4-chloro-15-cyclopropyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 35 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.730 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571471&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591928 473132620 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206758 Cc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C35H36ClN3O4/c1-21-29-30-27(36)17-16-26-25(12-8-20-42-28-13-7-10-22-9-3-4-11-24(22)28)33(35(40)41)39(32(26)30)18-5-6-19-43-34(23-14-15-23)31(29)37-38(21)2/h3-4,7,9-11,13,16-17,23,34H,5-6,8,12,14-15,18-20H2,1-2H3,(H,40,41) ZYTWBPWAQMGSAQ-UHFFFAOYSA-N 571471 (+)-4-chloro-15-cyclopropyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 35 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571471&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591928 473132620 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206759 Cc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C35H36ClN3O4/c1-21-29-30-27(36)17-16-26-25(12-8-20-42-28-13-7-10-22-9-3-4-11-24(22)28)33(35(40)41)39(32(26)30)18-5-6-19-43-34(23-14-15-23)31(29)37-38(21)2/h3-4,7,9-11,13,16-17,23,34H,5-6,8,12,14-15,18-20H2,1-2H3,(H,40,41) ZYTWBPWAQMGSAQ-UHFFFAOYSA-N 571471 (+)-4-chloro-15-cyclopropyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 35 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571471&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591928 473132620 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206760 Cc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C35H36ClN3O4/c1-21-29-30-27(36)17-16-26-25(12-8-20-42-28-13-7-10-22-9-3-4-11-24(22)28)33(35(40)41)39(32(26)30)18-5-6-19-43-34(23-14-15-23)31(29)37-38(21)2/h3-4,7,9-11,13,16-17,23,34H,5-6,8,12,14-15,18-20H2,1-2H3,(H,40,41) ZYTWBPWAQMGSAQ-UHFFFAOYSA-N 571472 (−)-4-chloro-15-cyclopropyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 36 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 280 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571472&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591928 473132621 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206761 Cc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C35H36ClN3O4/c1-21-29-30-27(36)17-16-26-25(12-8-20-42-28-13-7-10-22-9-3-4-11-24(22)28)33(35(40)41)39(32(26)30)18-5-6-19-43-34(23-14-15-23)31(29)37-38(21)2/h3-4,7,9-11,13,16-17,23,34H,5-6,8,12,14-15,18-20H2,1-2H3,(H,40,41) ZYTWBPWAQMGSAQ-UHFFFAOYSA-N 571472 (−)-4-chloro-15-cyclopropyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 36 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 14600 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571472&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591928 473132621 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206762 Cc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C35H36ClN3O4/c1-21-29-30-27(36)17-16-26-25(12-8-20-42-28-13-7-10-22-9-3-4-11-24(22)28)33(35(40)41)39(32(26)30)18-5-6-19-43-34(23-14-15-23)31(29)37-38(21)2/h3-4,7,9-11,13,16-17,23,34H,5-6,8,12,14-15,18-20H2,1-2H3,(H,40,41) ZYTWBPWAQMGSAQ-UHFFFAOYSA-N 571472 (−)-4-chloro-15-cyclopropyl-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 36 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 13800 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571472&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591928 473132621 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206763 COCCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C35H38ClN3O5/c1-22-30-31-27(36)16-15-26-25(13-9-20-43-28-14-8-11-23-10-4-5-12-24(23)28)34(35(40)41)39(33(26)31)18-6-7-19-44-29(17-21-42-3)32(30)37-38(22)2/h4-5,8,10-12,14-16,29H,6-7,9,13,17-21H2,1-3H3,(H,40,41) UGRSAOFGYCVXJI-UHFFFAOYSA-N 571473 (rac)-4-chloro-(15-rac)-(2-methoxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 37 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.480 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571473&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591855 473132622 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206764 COCCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C35H38ClN3O5/c1-22-30-31-27(36)16-15-26-25(13-9-20-43-28-14-8-11-23-10-4-5-12-24(23)28)34(35(40)41)39(33(26)31)18-6-7-19-44-29(17-21-42-3)32(30)37-38(22)2/h4-5,8,10-12,14-16,29H,6-7,9,13,17-21H2,1-3H3,(H,40,41) UGRSAOFGYCVXJI-UHFFFAOYSA-N 571473 (rac)-4-chloro-(15-rac)-(2-methoxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 37 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571473&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591855 473132622 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206765 COCCC1OCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C35H38ClN3O5/c1-22-30-31-27(36)16-15-26-25(13-9-20-43-28-14-8-11-23-10-4-5-12-24(23)28)34(35(40)41)39(33(26)31)18-6-7-19-44-29(17-21-42-3)32(30)37-38(22)2/h4-5,8,10-12,14-16,29H,6-7,9,13,17-21H2,1-3H3,(H,40,41) UGRSAOFGYCVXJI-UHFFFAOYSA-N 571473 (rac)-4-chloro-(15-rac)-(2-methoxyethyl)-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 37 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 17100 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571473&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591855 473132622 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206766 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C36H37ClFN3O4/c1-3-28-31-30-27(37)16-15-26-25(9-7-19-44-29-10-6-8-22-20-23(38)13-14-24(22)29)34(36(42)43)41(33(26)30)17-4-5-18-45-35(21-11-12-21)32(31)39-40(28)2/h6,8,10,13-16,20-21,35H,3-5,7,9,11-12,17-19H2,1-2H3,(H,42,43) YJGZWMUDDMXOHU-UHFFFAOYSA-N 571474 (rac)-4-chloro-(15-rac)-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 38 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571474&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591826 473132623 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206767 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C36H37ClFN3O4/c1-3-28-31-30-27(37)16-15-26-25(9-7-19-44-29-10-6-8-22-20-23(38)13-14-24(22)29)34(36(42)43)41(33(26)30)17-4-5-18-45-35(21-11-12-21)32(31)39-40(28)2/h6,8,10,13-16,20-21,35H,3-5,7,9,11-12,17-19H2,1-2H3,(H,42,43) YJGZWMUDDMXOHU-UHFFFAOYSA-N 571474 (rac)-4-chloro-(15-rac)-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 38 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 16300 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571474&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591826 473132623 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206768 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C36H37ClFN3O4/c1-3-28-31-30-27(37)16-15-26-25(9-7-19-44-29-10-6-8-22-20-23(38)13-14-24(22)29)34(36(42)43)41(33(26)30)17-4-5-18-45-35(21-11-12-21)32(31)39-40(28)2/h6,8,10,13-16,20-21,35H,3-5,7,9,11-12,17-19H2,1-2H3,(H,42,43) YJGZWMUDDMXOHU-UHFFFAOYSA-N 571474 (rac)-4-chloro-(15-rac)-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 38 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571474&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591826 473132623 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206769 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C36H37ClFN3O4/c1-3-28-31-30-27(37)16-15-26-25(9-7-19-44-29-10-6-8-22-20-23(38)13-14-24(22)29)34(36(42)43)41(33(26)30)17-4-5-18-45-35(21-11-12-21)32(31)39-40(28)2/h6,8,10,13-16,20-21,35H,3-5,7,9,11-12,17-19H2,1-2H3,(H,42,43) YJGZWMUDDMXOHU-UHFFFAOYSA-N 571475 (+)-4-chloro-15-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 39 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.720 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571475&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591826 473132624 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206770 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C36H37ClFN3O4/c1-3-28-31-30-27(37)16-15-26-25(9-7-19-44-29-10-6-8-22-20-23(38)13-14-24(22)29)34(36(42)43)41(33(26)30)17-4-5-18-45-35(21-11-12-21)32(31)39-40(28)2/h6,8,10,13-16,20-21,35H,3-5,7,9,11-12,17-19H2,1-2H3,(H,42,43) YJGZWMUDDMXOHU-UHFFFAOYSA-N 571475 (+)-4-chloro-15-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 39 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 15100 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571475&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591826 473132624 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206771 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C36H37ClFN3O4/c1-3-28-31-30-27(37)16-15-26-25(9-7-19-44-29-10-6-8-22-20-23(38)13-14-24(22)29)34(36(42)43)41(33(26)30)17-4-5-18-45-35(21-11-12-21)32(31)39-40(28)2/h6,8,10,13-16,20-21,35H,3-5,7,9,11-12,17-19H2,1-2H3,(H,42,43) YJGZWMUDDMXOHU-UHFFFAOYSA-N 571475 (+)-4-chloro-15-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 39 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 18100 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571475&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591826 473132624 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206772 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C36H37ClFN3O4/c1-3-28-31-30-27(37)16-15-26-25(9-7-19-44-29-10-6-8-22-20-23(38)13-14-24(22)29)34(36(42)43)41(33(26)30)17-4-5-18-45-35(21-11-12-21)32(31)39-40(28)2/h6,8,10,13-16,20-21,35H,3-5,7,9,11-12,17-19H2,1-2H3,(H,42,43) YJGZWMUDDMXOHU-UHFFFAOYSA-N 571476 (−)-4-chloro-15-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 40 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 48.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571476&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591826 473132625 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206773 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C36H37ClFN3O4/c1-3-28-31-30-27(37)16-15-26-25(9-7-19-44-29-10-6-8-22-20-23(38)13-14-24(22)29)34(36(42)43)41(33(26)30)17-4-5-18-45-35(21-11-12-21)32(31)39-40(28)2/h6,8,10,13-16,20-21,35H,3-5,7,9,11-12,17-19H2,1-2H3,(H,42,43) YJGZWMUDDMXOHU-UHFFFAOYSA-N 571476 (−)-4-chloro-15-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 40 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 18300 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571476&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591826 473132625 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206774 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)C1CC1 InChI=1S/C36H37ClFN3O4/c1-3-28-31-30-27(37)16-15-26-25(9-7-19-44-29-10-6-8-22-20-23(38)13-14-24(22)29)34(36(42)43)41(33(26)30)17-4-5-18-45-35(21-11-12-21)32(31)39-40(28)2/h6,8,10,13-16,20-21,35H,3-5,7,9,11-12,17-19H2,1-2H3,(H,42,43) YJGZWMUDDMXOHU-UHFFFAOYSA-N 571476 (−)-4-chloro-15-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 40 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571476&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591826 473132625 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206775 CCc1c-2c(nn1C)C(CCOC)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H39ClFN3O5/c1-4-28-32-31-27(37)15-14-26-25(10-8-19-45-29-11-7-9-22-21-23(38)12-13-24(22)29)35(36(42)43)41(34(26)31)17-5-6-18-46-30(16-20-44-3)33(32)39-40(28)2/h7,9,11-15,21,30H,4-6,8,10,16-20H2,1-3H3,(H,42,43) ULHMAHZGCJFFEN-UHFFFAOYSA-N 571477 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(2-methoxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 41 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.520 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571477&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591893 473132626 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206776 CCc1c-2c(nn1C)C(CCOC)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H39ClFN3O5/c1-4-28-32-31-27(37)15-14-26-25(10-8-19-45-29-11-7-9-22-21-23(38)12-13-24(22)29)35(36(42)43)41(34(26)31)17-5-6-18-46-30(16-20-44-3)33(32)39-40(28)2/h7,9,11-15,21,30H,4-6,8,10,16-20H2,1-3H3,(H,42,43) ULHMAHZGCJFFEN-UHFFFAOYSA-N 571477 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(2-methoxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 41 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 18100 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571477&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591893 473132626 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206777 CCc1c-2c(nn1C)C(CCOC)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H39ClFN3O5/c1-4-28-32-31-27(37)15-14-26-25(10-8-19-45-29-11-7-9-22-21-23(38)12-13-24(22)29)35(36(42)43)41(34(26)31)17-5-6-18-46-30(16-20-44-3)33(32)39-40(28)2/h7,9,11-15,21,30H,4-6,8,10,16-20H2,1-3H3,(H,42,43) ULHMAHZGCJFFEN-UHFFFAOYSA-N 571477 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(2-methoxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 41 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 15000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571477&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591893 473132626 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206778 CCc1c-2c(nn1C)C(CCOC)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H39ClFN3O5/c1-4-28-32-31-27(37)15-14-26-25(10-8-19-45-29-11-7-9-22-21-23(38)12-13-24(22)29)35(36(42)43)41(34(26)31)17-5-6-18-46-30(16-20-44-3)33(32)39-40(28)2/h7,9,11-15,21,30H,4-6,8,10,16-20H2,1-3H3,(H,42,43) ULHMAHZGCJFFEN-UHFFFAOYSA-N 571478 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-methoxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 42 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.330 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571478&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591893 473132627 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206779 CCc1c-2c(nn1C)C(CCOC)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H39ClFN3O5/c1-4-28-32-31-27(37)15-14-26-25(10-8-19-45-29-11-7-9-22-21-23(38)12-13-24(22)29)35(36(42)43)41(34(26)31)17-5-6-18-46-30(16-20-44-3)33(32)39-40(28)2/h7,9,11-15,21,30H,4-6,8,10,16-20H2,1-3H3,(H,42,43) ULHMAHZGCJFFEN-UHFFFAOYSA-N 571478 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-methoxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 42 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571478&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591893 473132627 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206780 CCc1c-2c(nn1C)C(CCOC)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H39ClFN3O5/c1-4-28-32-31-27(37)15-14-26-25(10-8-19-45-29-11-7-9-22-21-23(38)12-13-24(22)29)35(36(42)43)41(34(26)31)17-5-6-18-46-30(16-20-44-3)33(32)39-40(28)2/h7,9,11-15,21,30H,4-6,8,10,16-20H2,1-3H3,(H,42,43) ULHMAHZGCJFFEN-UHFFFAOYSA-N 571478 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-methoxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 42 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 15000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571478&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591893 473132627 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206781 CCc1c-2c(nn1C)C(CCOC)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H39ClFN3O5/c1-4-28-32-31-27(37)15-14-26-25(10-8-19-45-29-11-7-9-22-21-23(38)12-13-24(22)29)35(36(42)43)41(34(26)31)17-5-6-18-46-30(16-20-44-3)33(32)39-40(28)2/h7,9,11-15,21,30H,4-6,8,10,16-20H2,1-3H3,(H,42,43) ULHMAHZGCJFFEN-UHFFFAOYSA-N 571479 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-methoxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 43 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 88.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571479&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591893 473132628 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206782 CCc1c-2c(nn1C)C(CCOC)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H39ClFN3O5/c1-4-28-32-31-27(37)15-14-26-25(10-8-19-45-29-11-7-9-22-21-23(38)12-13-24(22)29)35(36(42)43)41(34(26)31)17-5-6-18-46-30(16-20-44-3)33(32)39-40(28)2/h7,9,11-15,21,30H,4-6,8,10,16-20H2,1-3H3,(H,42,43) ULHMAHZGCJFFEN-UHFFFAOYSA-N 571479 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-methoxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 43 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 19300 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571479&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591893 473132628 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206783 CCc1c-2c(nn1C)C(CCOC)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H39ClFN3O5/c1-4-28-32-31-27(37)15-14-26-25(10-8-19-45-29-11-7-9-22-21-23(38)12-13-24(22)29)35(36(42)43)41(34(26)31)17-5-6-18-46-30(16-20-44-3)33(32)39-40(28)2/h7,9,11-15,21,30H,4-6,8,10,16-20H2,1-3H3,(H,42,43) ULHMAHZGCJFFEN-UHFFFAOYSA-N 571479 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-methoxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 43 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 17200 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571479&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591893 473132628 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206784 CCc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C35H37ClFN3O5/c1-3-27-31-30-26(36)14-13-25-24(9-7-19-44-28-10-6-8-21-20-22(37)11-12-23(21)28)34(35(42)43)40(33(25)30)16-4-5-18-45-29(15-17-41)32(31)38-39(27)2/h6,8,10-14,20,29,41H,3-5,7,9,15-19H2,1-2H3,(H,42,43) YBBZCAXSRUNKMD-UHFFFAOYSA-N 571480 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(2-hydroxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 44 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.390 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571480&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591816 473132629 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206785 CCc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C35H37ClFN3O5/c1-3-27-31-30-26(36)14-13-25-24(9-7-19-44-28-10-6-8-21-20-22(37)11-12-23(21)28)34(35(42)43)40(33(25)30)16-4-5-18-45-29(15-17-41)32(31)38-39(27)2/h6,8,10-14,20,29,41H,3-5,7,9,15-19H2,1-2H3,(H,42,43) YBBZCAXSRUNKMD-UHFFFAOYSA-N 571480 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(2-hydroxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 44 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571480&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591816 473132629 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206786 CCc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C35H37ClFN3O5/c1-3-27-31-30-26(36)14-13-25-24(9-7-19-44-28-10-6-8-21-20-22(37)11-12-23(21)28)34(35(42)43)40(33(25)30)16-4-5-18-45-29(15-17-41)32(31)38-39(27)2/h6,8,10-14,20,29,41H,3-5,7,9,15-19H2,1-2H3,(H,42,43) YBBZCAXSRUNKMD-UHFFFAOYSA-N 571480 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(2-hydroxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 44 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 12500 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571480&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591816 473132629 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206787 CCc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C35H37ClFN3O5/c1-3-27-31-30-26(36)14-13-25-24(9-7-19-44-28-10-6-8-21-20-22(37)11-12-23(21)28)34(35(42)43)40(33(25)30)16-4-5-18-45-29(15-17-41)32(31)38-39(27)2/h6,8,10-14,20,29,41H,3-5,7,9,15-19H2,1-2H3,(H,42,43) YBBZCAXSRUNKMD-UHFFFAOYSA-N 571481 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 45 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.550 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571481&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591816 473132630 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206788 CCc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C35H37ClFN3O5/c1-3-27-31-30-26(36)14-13-25-24(9-7-19-44-28-10-6-8-21-20-22(37)11-12-23(21)28)34(35(42)43)40(33(25)30)16-4-5-18-45-29(15-17-41)32(31)38-39(27)2/h6,8,10-14,20,29,41H,3-5,7,9,15-19H2,1-2H3,(H,42,43) YBBZCAXSRUNKMD-UHFFFAOYSA-N 571481 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 45 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571481&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591816 473132630 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206789 CCc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C35H37ClFN3O5/c1-3-27-31-30-26(36)14-13-25-24(9-7-19-44-28-10-6-8-21-20-22(37)11-12-23(21)28)34(35(42)43)40(33(25)30)16-4-5-18-45-29(15-17-41)32(31)38-39(27)2/h6,8,10-14,20,29,41H,3-5,7,9,15-19H2,1-2H3,(H,42,43) YBBZCAXSRUNKMD-UHFFFAOYSA-N 571481 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 45 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571481&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591816 473132630 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206790 CCc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C35H37ClFN3O5/c1-3-27-31-30-26(36)14-13-25-24(9-7-19-44-28-10-6-8-21-20-22(37)11-12-23(21)28)34(35(42)43)40(33(25)30)16-4-5-18-45-29(15-17-41)32(31)38-39(27)2/h6,8,10-14,20,29,41H,3-5,7,9,15-19H2,1-2H3,(H,42,43) YBBZCAXSRUNKMD-UHFFFAOYSA-N 571482 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 46 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 36.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571482&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591816 473132631 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206791 CCc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C35H37ClFN3O5/c1-3-27-31-30-26(36)14-13-25-24(9-7-19-44-28-10-6-8-21-20-22(37)11-12-23(21)28)34(35(42)43)40(33(25)30)16-4-5-18-45-29(15-17-41)32(31)38-39(27)2/h6,8,10-14,20,29,41H,3-5,7,9,15-19H2,1-2H3,(H,42,43) YBBZCAXSRUNKMD-UHFFFAOYSA-N 571482 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 46 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571482&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591816 473132631 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206792 CCc1c-2c(nn1C)C(CCO)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C35H37ClFN3O5/c1-3-27-31-30-26(36)14-13-25-24(9-7-19-44-28-10-6-8-21-20-22(37)11-12-23(21)28)34(35(42)43)40(33(25)30)16-4-5-18-45-29(15-17-41)32(31)38-39(27)2/h6,8,10-14,20,29,41H,3-5,7,9,15-19H2,1-2H3,(H,42,43) YBBZCAXSRUNKMD-UHFFFAOYSA-N 571482 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxyethyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 46 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571482&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591816 473132631 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206793 CCc1c-2c(nn1C)[C@@H](CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47)/t33-/m1/s1 RQXSLNDYCDRXAC-MGBGTMOVSA-N 571483 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15R)-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 47 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.370 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571483&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591867 473132632 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206794 CCc1c-2c(nn1C)[C@@H](CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47)/t33-/m1/s1 RQXSLNDYCDRXAC-MGBGTMOVSA-N 571483 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15R)-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 47 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571483&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591867 473132632 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206795 CCc1c-2c(nn1C)[C@@H](CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47)/t33-/m1/s1 RQXSLNDYCDRXAC-MGBGTMOVSA-N 571483 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15R)-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 47 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571483&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591867 473132632 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206796 CCc1c-2c(nn1C)[C@@H](CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47)/t33-/m1/s1 RQXSLNDYCDRXAC-MGBGTMOVSA-N 571484 (15R)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt::US11440923, Example 48 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.60 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571484&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591867 473132633 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206797 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C39H44F2N4O5/c1-3-31-35-34-30(41)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(40)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) SJDMDUULGAVTFD-UHFFFAOYSA-N 571485 (rac)-3-Ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 49 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.850 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571485&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591976 473132634 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206798 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C39H44F2N4O5/c1-3-31-35-34-30(41)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(40)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) SJDMDUULGAVTFD-UHFFFAOYSA-N 571485 (rac)-3-Ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 49 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571485&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591976 473132634 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206799 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C39H44F2N4O5/c1-3-31-35-34-30(41)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(40)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) SJDMDUULGAVTFD-UHFFFAOYSA-N 571485 (rac)-3-Ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 49 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571485&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591976 473132634 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206800 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C39H44F2N4O5/c1-3-31-35-34-30(41)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(40)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) SJDMDUULGAVTFD-UHFFFAOYSA-N 571486 (+)-3-ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 50 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.480 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571486&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591976 473132635 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206801 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C39H44F2N4O5/c1-3-31-35-34-30(41)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(40)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) SJDMDUULGAVTFD-UHFFFAOYSA-N 571486 (+)-3-ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 50 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571486&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591976 473132635 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206802 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C39H44F2N4O5/c1-3-31-35-34-30(41)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(40)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) SJDMDUULGAVTFD-UHFFFAOYSA-N 571486 (+)-3-ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 50 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571486&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591976 473132635 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206803 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C39H44F2N4O5/c1-3-31-35-34-30(41)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(40)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) SJDMDUULGAVTFD-UHFFFAOYSA-N 571487 (−)-3-ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 51 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 60.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571487&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591976 473132636 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206804 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C39H44F2N4O5/c1-3-31-35-34-30(41)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(40)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) SJDMDUULGAVTFD-UHFFFAOYSA-N 571487 (−)-3-ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 51 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571487&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591976 473132636 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206805 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(F)c-2c13 InChI=1S/C39H44F2N4O5/c1-3-31-35-34-30(41)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(40)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47) SJDMDUULGAVTFD-UHFFFAOYSA-N 571487 (−)-3-ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 51 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571487&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591976 473132636 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206806 CCc1c-2c(nn1C)C(CC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClFN3O5/c1-5-28-32-31-27(38)16-15-26-25(11-9-19-46-29-12-8-10-22-20-23(39)13-14-24(22)29)35(36(43)44)42(34(26)31)17-6-7-18-47-30(21-37(2,3)45)33(32)40-41(28)4/h8,10,12-16,20,30,45H,5-7,9,11,17-19,21H2,1-4H3,(H,43,44) URSSGZZZWGELEI-UHFFFAOYSA-N 571488 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(2-hydroxy-2-methylpropyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 52 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.880 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571488 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571488&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591853 473132637 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206807 CCc1c-2c(nn1C)C(CC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClFN3O5/c1-5-28-32-31-27(38)16-15-26-25(11-9-19-46-29-12-8-10-22-20-23(39)13-14-24(22)29)35(36(43)44)42(34(26)31)17-6-7-18-47-30(21-37(2,3)45)33(32)40-41(28)4/h8,10,12-16,20,30,45H,5-7,9,11,17-19,21H2,1-4H3,(H,43,44) URSSGZZZWGELEI-UHFFFAOYSA-N 571488 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(2-hydroxy-2-methylpropyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 52 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 15900 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571488 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571488&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591853 473132637 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206808 CCc1c-2c(nn1C)C(CC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClFN3O5/c1-5-28-32-31-27(38)16-15-26-25(11-9-19-46-29-12-8-10-22-20-23(39)13-14-24(22)29)35(36(43)44)42(34(26)31)17-6-7-18-47-30(21-37(2,3)45)33(32)40-41(28)4/h8,10,12-16,20,30,45H,5-7,9,11,17-19,21H2,1-4H3,(H,43,44) URSSGZZZWGELEI-UHFFFAOYSA-N 571488 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(2-hydroxy-2-methylpropyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 52 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 14700 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571488 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571488&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591853 473132637 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206809 CCc1c-2c(nn1C)C(CC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClFN3O5/c1-5-28-32-31-27(38)16-15-26-25(11-9-19-46-29-12-8-10-22-20-23(39)13-14-24(22)29)35(36(43)44)42(34(26)31)17-6-7-18-47-30(21-37(2,3)45)33(32)40-41(28)4/h8,10,12-16,20,30,45H,5-7,9,11,17-19,21H2,1-4H3,(H,43,44) URSSGZZZWGELEI-UHFFFAOYSA-N 571489 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxy-2-methylpropyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 53 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.410 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571489&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591853 473132638 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206810 CCc1c-2c(nn1C)C(CC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClFN3O5/c1-5-28-32-31-27(38)16-15-26-25(11-9-19-46-29-12-8-10-22-20-23(39)13-14-24(22)29)35(36(43)44)42(34(26)31)17-6-7-18-47-30(21-37(2,3)45)33(32)40-41(28)4/h8,10,12-16,20,30,45H,5-7,9,11,17-19,21H2,1-4H3,(H,43,44) URSSGZZZWGELEI-UHFFFAOYSA-N 571489 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxy-2-methylpropyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 53 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 17000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571489&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591853 473132638 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206811 CCc1c-2c(nn1C)C(CC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClFN3O5/c1-5-28-32-31-27(38)16-15-26-25(11-9-19-46-29-12-8-10-22-20-23(39)13-14-24(22)29)35(36(43)44)42(34(26)31)17-6-7-18-47-30(21-37(2,3)45)33(32)40-41(28)4/h8,10,12-16,20,30,45H,5-7,9,11,17-19,21H2,1-4H3,(H,43,44) URSSGZZZWGELEI-UHFFFAOYSA-N 571489 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxy-2-methylpropyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 53 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 11000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571489&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591853 473132638 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206812 CCc1c-2c(nn1C)C(CC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClFN3O5/c1-5-28-32-31-27(38)16-15-26-25(11-9-19-46-29-12-8-10-22-20-23(39)13-14-24(22)29)35(36(43)44)42(34(26)31)17-6-7-18-47-30(21-37(2,3)45)33(32)40-41(28)4/h8,10,12-16,20,30,45H,5-7,9,11,17-19,21H2,1-4H3,(H,43,44) URSSGZZZWGELEI-UHFFFAOYSA-N 571490 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxy-2-methylpropyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 21::US11440923, Example 54 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 47.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571490&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591853 473132639 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206813 CCc1c-2c(nn1C)C(CC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClFN3O5/c1-5-28-32-31-27(38)16-15-26-25(11-9-19-46-29-12-8-10-22-20-23(39)13-14-24(22)29)35(36(43)44)42(34(26)31)17-6-7-18-47-30(21-37(2,3)45)33(32)40-41(28)4/h8,10,12-16,20,30,45H,5-7,9,11,17-19,21H2,1-4H3,(H,43,44) URSSGZZZWGELEI-UHFFFAOYSA-N 571490 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxy-2-methylpropyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 21::US11440923, Example 54 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571490&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591853 473132639 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206814 CCc1c-2c(nn1C)C(CC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClFN3O5/c1-5-28-32-31-27(38)16-15-26-25(11-9-19-46-29-12-8-10-22-20-23(39)13-14-24(22)29)35(36(43)44)42(34(26)31)17-6-7-18-47-30(21-37(2,3)45)33(32)40-41(28)4/h8,10,12-16,20,30,45H,5-7,9,11,17-19,21H2,1-4H3,(H,43,44) URSSGZZZWGELEI-UHFFFAOYSA-N 571490 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(2-hydroxy-2-methylpropyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 21::US11440923, Example 54 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 14300 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571490&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591853 473132639 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206815 CCc1c-2c(nn1C)C(CCN1CCC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O4/c1-3-30-34-33-29(40)14-13-28-27(9-7-21-50-31-10-6-8-24-22-25(41)11-12-26(24)31)37(38(48)49)47(36(28)33)17-4-5-20-51-32(35(34)44-45(30)2)15-18-46-19-16-39(42,43)23-46/h6,8,10-14,22,32H,3-5,7,9,15-21,23H2,1-2H3,(H,48,49) AGJFZNQFGUFEFK-UHFFFAOYSA-N 571491 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—2-hydroxypropane-1,2,3-tricarboxylic Acid Salt::US11440923, Example 55::US11440923, Example 56::US11440923, Example 57::US11440923, Example 58 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.780 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571491&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591910 473132640 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206816 CCc1c-2c(nn1C)C(CCN1CCC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O4/c1-3-30-34-33-29(40)14-13-28-27(9-7-21-50-31-10-6-8-24-22-25(41)11-12-26(24)31)37(38(48)49)47(36(28)33)17-4-5-20-51-32(35(34)44-45(30)2)15-18-46-19-16-39(42,43)23-46/h6,8,10-14,22,32H,3-5,7,9,15-21,23H2,1-2H3,(H,48,49) AGJFZNQFGUFEFK-UHFFFAOYSA-N 571491 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—2-hydroxypropane-1,2,3-tricarboxylic Acid Salt::US11440923, Example 55::US11440923, Example 56::US11440923, Example 57::US11440923, Example 58 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571491&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591910 473132640 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206817 CCc1c-2c(nn1C)C(CCN1CCC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O4/c1-3-30-34-33-29(40)14-13-28-27(9-7-21-50-31-10-6-8-24-22-25(41)11-12-26(24)31)37(38(48)49)47(36(28)33)17-4-5-20-51-32(35(34)44-45(30)2)15-18-46-19-16-39(42,43)23-46/h6,8,10-14,22,32H,3-5,7,9,15-21,23H2,1-2H3,(H,48,49) AGJFZNQFGUFEFK-UHFFFAOYSA-N 571491 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—2-hydroxypropane-1,2,3-tricarboxylic Acid Salt::US11440923, Example 55::US11440923, Example 56::US11440923, Example 57::US11440923, Example 58 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571491&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591910 473132640 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206818 CCc1c-2c(nn1C)C(CCN1CCC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O4/c1-3-30-34-33-29(40)14-13-28-27(9-7-21-50-31-10-6-8-24-22-25(41)11-12-26(24)31)37(38(48)49)47(36(28)33)17-4-5-20-51-32(35(34)44-45(30)2)15-18-46-19-16-39(42,43)23-46/h6,8,10-14,22,32H,3-5,7,9,15-21,23H2,1-2H3,(H,48,49) AGJFZNQFGUFEFK-UHFFFAOYSA-N 571491 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—2-hydroxypropane-1,2,3-tricarboxylic Acid Salt::US11440923, Example 55::US11440923, Example 56::US11440923, Example 57::US11440923, Example 58 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.840 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571491&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591910 473132640 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206819 CCc1c-2c(nn1C)C(CCN1CCC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O4/c1-3-30-34-33-29(40)14-13-28-27(9-7-21-50-31-10-6-8-24-22-25(41)11-12-26(24)31)37(38(48)49)47(36(28)33)17-4-5-20-51-32(35(34)44-45(30)2)15-18-46-19-16-39(42,43)23-46/h6,8,10-14,22,32H,3-5,7,9,15-21,23H2,1-2H3,(H,48,49) AGJFZNQFGUFEFK-UHFFFAOYSA-N 571491 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—2-hydroxypropane-1,2,3-tricarboxylic Acid Salt::US11440923, Example 55::US11440923, Example 56::US11440923, Example 57::US11440923, Example 58 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571491&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591910 473132640 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206820 CCc1c-2c(nn1C)C(CCN1CCC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O4/c1-3-30-34-33-29(40)14-13-28-27(9-7-21-50-31-10-6-8-24-22-25(41)11-12-26(24)31)37(38(48)49)47(36(28)33)17-4-5-20-51-32(35(34)44-45(30)2)15-18-46-19-16-39(42,43)23-46/h6,8,10-14,22,32H,3-5,7,9,15-21,23H2,1-2H3,(H,48,49) AGJFZNQFGUFEFK-UHFFFAOYSA-N 571491 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—2-hydroxypropane-1,2,3-tricarboxylic Acid Salt::US11440923, Example 55::US11440923, Example 56::US11440923, Example 57::US11440923, Example 58 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571491&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591910 473132640 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206821 CCc1c-2c(nn1C)C(CCN1CCC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O4/c1-3-30-34-33-29(40)14-13-28-27(9-7-21-50-31-10-6-8-24-22-25(41)11-12-26(24)31)37(38(48)49)47(36(28)33)17-4-5-20-51-32(35(34)44-45(30)2)15-18-46-19-16-39(42,43)23-46/h6,8,10-14,22,32H,3-5,7,9,15-21,23H2,1-2H3,(H,48,49) AGJFZNQFGUFEFK-UHFFFAOYSA-N 571491 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—2-hydroxypropane-1,2,3-tricarboxylic Acid Salt::US11440923, Example 55::US11440923, Example 56::US11440923, Example 57::US11440923, Example 58 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 160 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571491&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591910 473132640 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206822 CCc1c-2c(nn1C)C(CCN1CCC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O4/c1-3-30-34-33-29(40)14-13-28-27(9-7-21-50-31-10-6-8-24-22-25(41)11-12-26(24)31)37(38(48)49)47(36(28)33)17-4-5-20-51-32(35(34)44-45(30)2)15-18-46-19-16-39(42,43)23-46/h6,8,10-14,22,32H,3-5,7,9,15-21,23H2,1-2H3,(H,48,49) AGJFZNQFGUFEFK-UHFFFAOYSA-N 571491 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—2-hydroxypropane-1,2,3-tricarboxylic Acid Salt::US11440923, Example 55::US11440923, Example 56::US11440923, Example 57::US11440923, Example 58 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571491&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591910 473132640 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206823 CCc1c-2c(nn1C)C(CCN1CCC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O4/c1-3-30-34-33-29(40)14-13-28-27(9-7-21-50-31-10-6-8-24-22-25(41)11-12-26(24)31)37(38(48)49)47(36(28)33)17-4-5-20-51-32(35(34)44-45(30)2)15-18-46-19-16-39(42,43)23-46/h6,8,10-14,22,32H,3-5,7,9,15-21,23H2,1-2H3,(H,48,49) AGJFZNQFGUFEFK-UHFFFAOYSA-N 571491 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—2-hydroxypropane-1,2,3-tricarboxylic Acid Salt::US11440923, Example 55::US11440923, Example 56::US11440923, Example 57::US11440923, Example 58 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571491&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591910 473132640 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206824 CCc1c-2c(nn1C)C(CCN1CCC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O4/c1-3-30-34-33-29(40)14-13-28-27(9-7-21-50-31-10-6-8-24-22-25(41)11-12-26(24)31)37(38(48)49)47(36(28)33)17-4-5-20-51-32(35(34)44-45(30)2)15-18-46-19-16-39(42,43)23-46/h6,8,10-14,22,32H,3-5,7,9,15-21,23H2,1-2H3,(H,48,49) AGJFZNQFGUFEFK-UHFFFAOYSA-N 571491 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid—2-hydroxypropane-1,2,3-tricarboxylic Acid Salt::US11440923, Example 55::US11440923, Example 56::US11440923, Example 57::US11440923, Example 58 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.780 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571491&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591910 473132640 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206825 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)c1ccccc1 InChI=1S/C39H37ClFN3O4/c1-3-31-34-33-30(40)19-18-29-28(14-10-22-47-32-15-9-13-25-23-26(41)16-17-27(25)32)37(39(45)46)44(36(29)33)20-7-8-21-48-38(35(34)42-43(31)2)24-11-5-4-6-12-24/h4-6,9,11-13,15-19,23,38H,3,7-8,10,14,20-22H2,1-2H3,(H,45,46) RJNIBEXFQRAROW-UHFFFAOYSA-N 571495 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-phenyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 59 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.70 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571495 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571495&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591970 473132641 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206826 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)c1ccccc1 InChI=1S/C39H37ClFN3O4/c1-3-31-34-33-30(40)19-18-29-28(14-10-22-47-32-15-9-13-25-23-26(41)16-17-27(25)32)37(39(45)46)44(36(29)33)20-7-8-21-48-38(35(34)42-43(31)2)24-11-5-4-6-12-24/h4-6,9,11-13,15-19,23,38H,3,7-8,10,14,20-22H2,1-2H3,(H,45,46) RJNIBEXFQRAROW-UHFFFAOYSA-N 571495 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-phenyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 59 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 13200 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571495 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571495&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591970 473132641 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206827 CCc1c-2c(nn1C)C(OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)c1ccccc1 InChI=1S/C39H37ClFN3O4/c1-3-31-34-33-30(40)19-18-29-28(14-10-22-47-32-15-9-13-25-23-26(41)16-17-27(25)32)37(39(45)46)44(36(29)33)20-7-8-21-48-38(35(34)42-43(31)2)24-11-5-4-6-12-24/h4-6,9,11-13,15-19,23,38H,3,7-8,10,14,20-22H2,1-2H3,(H,45,46) RJNIBEXFQRAROW-UHFFFAOYSA-N 571495 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-phenyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 59 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571495 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571495&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591970 473132641 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206828 CCc1c-2c(nn1C)C(CCC1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H45ClFN3O5/c1-3-32-36-35-31(41)15-14-30-29(9-7-21-49-33-10-6-8-26-24-27(42)12-13-28(26)33)39(40(46)47)45(38(30)35)19-4-5-20-50-34(37(36)43-44(32)2)16-11-25-17-22-48-23-18-25/h6,8,10,12-15,24-25,34H,3-5,7,9,11,16-23H2,1-2H3,(H,46,47) VHMBNLMVMVJRRL-UHFFFAOYSA-N 571496 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(oxan-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 60 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.690 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571496&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591922 473132642 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206829 CCc1c-2c(nn1C)C(CCC1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H45ClFN3O5/c1-3-32-36-35-31(41)15-14-30-29(9-7-21-49-33-10-6-8-26-24-27(42)12-13-28(26)33)39(40(46)47)45(38(30)35)19-4-5-20-50-34(37(36)43-44(32)2)16-11-25-17-22-48-23-18-25/h6,8,10,12-15,24-25,34H,3-5,7,9,11,16-23H2,1-2H3,(H,46,47) VHMBNLMVMVJRRL-UHFFFAOYSA-N 571496 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(oxan-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 60 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 14100 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571496&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591922 473132642 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206830 CCc1c-2c(nn1C)C(CCC1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H45ClFN3O5/c1-3-32-36-35-31(41)15-14-30-29(9-7-21-49-33-10-6-8-26-24-27(42)12-13-28(26)33)39(40(46)47)45(38(30)35)19-4-5-20-50-34(37(36)43-44(32)2)16-11-25-17-22-48-23-18-25/h6,8,10,12-15,24-25,34H,3-5,7,9,11,16-23H2,1-2H3,(H,46,47) VHMBNLMVMVJRRL-UHFFFAOYSA-N 571496 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(oxan-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 60 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 15400 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571496&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591922 473132642 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206831 CCc1c-2c(nn1C)C(CCC1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H45ClFN3O5/c1-3-32-36-35-31(41)15-14-30-29(9-7-21-49-33-10-6-8-26-24-27(42)12-13-28(26)33)39(40(46)47)45(38(30)35)19-4-5-20-50-34(37(36)43-44(32)2)16-11-25-17-22-48-23-18-25/h6,8,10,12-15,24-25,34H,3-5,7,9,11,16-23H2,1-2H3,(H,46,47) VHMBNLMVMVJRRL-UHFFFAOYSA-N 571497 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(oxan-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 61 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.460 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571497&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591922 473132643 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206832 CCc1c-2c(nn1C)C(CCC1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H45ClFN3O5/c1-3-32-36-35-31(41)15-14-30-29(9-7-21-49-33-10-6-8-26-24-27(42)12-13-28(26)33)39(40(46)47)45(38(30)35)19-4-5-20-50-34(37(36)43-44(32)2)16-11-25-17-22-48-23-18-25/h6,8,10,12-15,24-25,34H,3-5,7,9,11,16-23H2,1-2H3,(H,46,47) VHMBNLMVMVJRRL-UHFFFAOYSA-N 571498 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(oxan-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 62 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 120 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571498 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571498&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591922 473132644 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206833 CCc1c-2c(nn1C)C(CCC1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H45ClFN3O5/c1-3-32-36-35-31(41)15-14-30-29(9-7-21-49-33-10-6-8-26-24-27(42)12-13-28(26)33)39(40(46)47)45(38(30)35)19-4-5-20-50-34(37(36)43-44(32)2)16-11-25-17-22-48-23-18-25/h6,8,10,12-15,24-25,34H,3-5,7,9,11,16-23H2,1-2H3,(H,46,47) VHMBNLMVMVJRRL-UHFFFAOYSA-N 571498 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(oxan-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 62 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571498 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571498&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591922 473132644 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206834 CCc1c-2c(nn1C)C(CCC1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H45ClFN3O5/c1-3-32-36-35-31(41)15-14-30-29(9-7-21-49-33-10-6-8-26-24-27(42)12-13-28(26)33)39(40(46)47)45(38(30)35)19-4-5-20-50-34(37(36)43-44(32)2)16-11-25-17-22-48-23-18-25/h6,8,10,12-15,24-25,34H,3-5,7,9,11,16-23H2,1-2H3,(H,46,47) VHMBNLMVMVJRRL-UHFFFAOYSA-N 571498 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(oxan-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 62 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571498 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571498&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591922 473132644 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206835 CCc1c-2c(nn1C)C(CCC1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H45ClFN3O5/c1-3-32-36-35-31(41)15-14-30-29(9-7-21-49-33-10-6-8-26-24-27(42)12-13-28(26)33)39(40(46)47)45(38(30)35)19-4-5-20-50-34(37(36)43-44(32)2)16-11-25-17-22-48-23-18-25/h6,8,10,12-15,24-25,34H,3-5,7,9,11,16-23H2,1-2H3,(H,46,47) VHMBNLMVMVJRRL-UHFFFAOYSA-N 571499 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(oxan-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 63 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.880 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571499 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571499&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591922 473132645 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206836 CCc1c-2c(nn1C)C(CCC1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H45ClFN3O5/c1-3-32-36-35-31(41)15-14-30-29(9-7-21-49-33-10-6-8-26-24-27(42)12-13-28(26)33)39(40(46)47)45(38(30)35)19-4-5-20-50-34(37(36)43-44(32)2)16-11-25-17-22-48-23-18-25/h6,8,10,12-15,24-25,34H,3-5,7,9,11,16-23H2,1-2H3,(H,46,47) VHMBNLMVMVJRRL-UHFFFAOYSA-N 571500 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(oxan-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 64 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 47.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571500 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571500&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591922 473132646 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206837 CCc1c-2c(nn1C)C(CCCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O5/c1-3-32-36-35-31(41)16-15-30-29(10-8-22-50-33-11-6-9-26-25-27(42)13-14-28(26)33)39(40(47)48)46(38(30)35)18-4-5-21-51-34(37(36)43-44(32)2)12-7-17-45-19-23-49-24-20-45/h6,9,11,13-16,25,34H,3-5,7-8,10,12,17-24H2,1-2H3,(H,47,48) IXLRDTNFEZCJQJ-UHFFFAOYSA-N 571501 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[3-(morpholin-4-yl)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 65 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571501&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591812 473133560 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206838 CCc1c-2c(nn1C)C(CCCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O5/c1-3-32-36-35-31(41)16-15-30-29(10-8-22-50-33-11-6-9-26-25-27(42)13-14-28(26)33)39(40(47)48)46(38(30)35)18-4-5-21-51-34(37(36)43-44(32)2)12-7-17-45-19-23-49-24-20-45/h6,9,11,13-16,25,34H,3-5,7-8,10,12,17-24H2,1-2H3,(H,47,48) IXLRDTNFEZCJQJ-UHFFFAOYSA-N 571501 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[3-(morpholin-4-yl)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 65 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571501&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591812 473133560 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206839 CCc1c-2c(nn1C)C(CCCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O5/c1-3-32-36-35-31(41)16-15-30-29(10-8-22-50-33-11-6-9-26-25-27(42)13-14-28(26)33)39(40(47)48)46(38(30)35)18-4-5-21-51-34(37(36)43-44(32)2)12-7-17-45-19-23-49-24-20-45/h6,9,11,13-16,25,34H,3-5,7-8,10,12,17-24H2,1-2H3,(H,47,48) IXLRDTNFEZCJQJ-UHFFFAOYSA-N 571501 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[3-(morpholin-4-yl)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 65 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571501&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591812 473133560 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206840 CCc1c-2c(nn1C)C(CCCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O5/c1-3-32-36-35-31(41)16-15-30-29(10-8-22-50-33-11-6-9-26-25-27(42)13-14-28(26)33)39(40(47)48)46(38(30)35)18-4-5-21-51-34(37(36)43-44(32)2)12-7-17-45-19-23-49-24-20-45/h6,9,11,13-16,25,34H,3-5,7-8,10,12,17-24H2,1-2H3,(H,47,48) IXLRDTNFEZCJQJ-UHFFFAOYSA-N 571502 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[3-(morpholin-4-yl)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 66 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.540 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571502&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591812 473132647 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206841 CCc1c-2c(nn1C)C(CCCN1CCOCC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O5/c1-3-32-36-35-31(41)16-15-30-29(10-8-22-50-33-11-6-9-26-25-27(42)13-14-28(26)33)39(40(47)48)46(38(30)35)18-4-5-21-51-34(37(36)43-44(32)2)12-7-17-45-19-23-49-24-20-45/h6,9,11,13-16,25,34H,3-5,7-8,10,12,17-24H2,1-2H3,(H,47,48) IXLRDTNFEZCJQJ-UHFFFAOYSA-N 571503 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[3-(morpholin-4-yl) propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 67 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 7.80 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571503 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571503&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591812 473132648 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206842 CCc1c-2c(nn1C)C(CCN1CCN(C)CC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-24-50-33-11-7-9-26-25-27(42)12-13-28(26)33)39(40(48)49)47(38(30)35)17-5-6-23-51-34(37(36)43-45(32)3)16-18-46-21-19-44(2)20-22-46/h7,9,11-15,25,34H,4-6,8,10,16-24H2,1-3H3,(H,48,49) ANVXUAKZIQJQID-UHFFFAOYSA-N 571504 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(4-methylpiperazin-1-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Mixture 1 of Stereoisomers)::US11440923, Example 68 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571504 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571504&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591788 473132649 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206843 CCc1c-2c(nn1C)C(CCN1CCN(C)CC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-24-50-33-11-7-9-26-25-27(42)12-13-28(26)33)39(40(48)49)47(38(30)35)17-5-6-23-51-34(37(36)43-45(32)3)16-18-46-21-19-44(2)20-22-46/h7,9,11-15,25,34H,4-6,8,10,16-24H2,1-3H3,(H,48,49) ANVXUAKZIQJQID-UHFFFAOYSA-N 571504 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(4-methylpiperazin-1-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Mixture 1 of Stereoisomers)::US11440923, Example 68 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571504 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571504&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591788 473132649 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206844 CCc1c-2c(nn1C)C(CCN1CCN(C)CC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-24-50-33-11-7-9-26-25-27(42)12-13-28(26)33)39(40(48)49)47(38(30)35)17-5-6-23-51-34(37(36)43-45(32)3)16-18-46-21-19-44(2)20-22-46/h7,9,11-15,25,34H,4-6,8,10,16-24H2,1-3H3,(H,48,49) ANVXUAKZIQJQID-UHFFFAOYSA-N 571504 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(4-methylpiperazin-1-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Mixture 1 of Stereoisomers)::US11440923, Example 68 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571504 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571504&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591788 473132649 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206845 CCc1c-2c(nn1C)C(CCN1CCN(C)CC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-24-50-33-11-7-9-26-25-27(42)12-13-28(26)33)39(40(48)49)47(38(30)35)17-5-6-23-51-34(37(36)43-45(32)3)16-18-46-21-19-44(2)20-22-46/h7,9,11-15,25,34H,4-6,8,10,16-24H2,1-3H3,(H,48,49) ANVXUAKZIQJQID-UHFFFAOYSA-N 571505 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(4-methylpiperazin-1-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Stereoisomer 1)::US11440923, Example 69 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.800 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571505&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591788 473132650 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206846 CCc1c-2c(nn1C)C(CCN1CCN(C)CC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-24-50-33-11-7-9-26-25-27(42)12-13-28(26)33)39(40(48)49)47(38(30)35)17-5-6-23-51-34(37(36)43-45(32)3)16-18-46-21-19-44(2)20-22-46/h7,9,11-15,25,34H,4-6,8,10,16-24H2,1-3H3,(H,48,49) ANVXUAKZIQJQID-UHFFFAOYSA-N 571506 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(4-methylpiperazin-1-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Stereoisomer 2)::US11440923, Example 70 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 68.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571506 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571506&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591788 473132651 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206847 CCc1c-2c(nn1C)C(CCN1CCN(C)CC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-24-50-33-11-7-9-26-25-27(42)12-13-28(26)33)39(40(48)49)47(38(30)35)17-5-6-23-51-34(37(36)43-45(32)3)16-18-46-21-19-44(2)20-22-46/h7,9,11-15,25,34H,4-6,8,10,16-24H2,1-3H3,(H,48,49) ANVXUAKZIQJQID-UHFFFAOYSA-N 571507 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(4-methylpiperazin-1-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Mixture 2 Od Stereoisomers)::US11440923, Example 71 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.00 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571507 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571507&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591788 473132652 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206848 CCc1c-2c(nn1C)C(CCN1CCN(C)CC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-24-50-33-11-7-9-26-25-27(42)12-13-28(26)33)39(40(48)49)47(38(30)35)17-5-6-23-51-34(37(36)43-45(32)3)16-18-46-21-19-44(2)20-22-46/h7,9,11-15,25,34H,4-6,8,10,16-24H2,1-3H3,(H,48,49) ANVXUAKZIQJQID-UHFFFAOYSA-N 571507 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(4-methylpiperazin-1-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Mixture 2 Od Stereoisomers)::US11440923, Example 71 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571507 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571507&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591788 473132652 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206849 CCc1c-2c(nn1C)C(CCN1CCN(C)CC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-24-50-33-11-7-9-26-25-27(42)12-13-28(26)33)39(40(48)49)47(38(30)35)17-5-6-23-51-34(37(36)43-45(32)3)16-18-46-21-19-44(2)20-22-46/h7,9,11-15,25,34H,4-6,8,10,16-24H2,1-3H3,(H,48,49) ANVXUAKZIQJQID-UHFFFAOYSA-N 571507 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-(15-rac)-[2-(4-methylpiperazin-1-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Mixture 2 Od Stereoisomers)::US11440923, Example 71 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571507 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571507&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591788 473132652 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206850 CCc1c-2c(nn1C)C(CCN1CCN(C)CC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-24-50-33-11-7-9-26-25-27(42)12-13-28(26)33)39(40(48)49)47(38(30)35)17-5-6-23-51-34(37(36)43-45(32)3)16-18-46-21-19-44(2)20-22-46/h7,9,11-15,25,34H,4-6,8,10,16-24H2,1-3H3,(H,48,49) ANVXUAKZIQJQID-UHFFFAOYSA-N 571508 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(4-methylpiperazin-1-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Stereoisomer 3)::US11440923, Example 72 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571508&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591788 473132653 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206851 CCc1c-2c(nn1C)C(CCN1CCN(C)CC1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-24-50-33-11-7-9-26-25-27(42)12-13-28(26)33)39(40(48)49)47(38(30)35)17-5-6-23-51-34(37(36)43-45(32)3)16-18-46-21-19-44(2)20-22-46/h7,9,11-15,25,34H,4-6,8,10,16-24H2,1-3H3,(H,48,49) ANVXUAKZIQJQID-UHFFFAOYSA-N 571509 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(4-methylpiperazin-1-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Stereoisomer 4)::US11440923, Example 73 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 13.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571509&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591788 473132654 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206852 CCc1c-2c(nn1C)C(CCC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClFN3O5/c1-5-29-33-32-28(39)16-15-27-26(11-9-21-47-30-12-8-10-23-22-24(40)13-14-25(23)30)36(37(44)45)43(35(27)32)19-6-7-20-48-31(17-18-38(2,3)46)34(33)41-42(29)4/h8,10,12-16,22,31,46H,5-7,9,11,17-21H2,1-4H3,(H,44,45) SNUPARNCTJQMEM-UHFFFAOYSA-N 571510 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(3-hydroxy-3-methylbutyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 74 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.00 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571510&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591959 473132655 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206853 CCc1c-2c(nn1C)C(CCC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClFN3O5/c1-5-29-33-32-28(39)16-15-27-26(11-9-21-47-30-12-8-10-23-22-24(40)13-14-25(23)30)36(37(44)45)43(35(27)32)19-6-7-20-48-31(17-18-38(2,3)46)34(33)41-42(29)4/h8,10,12-16,22,31,46H,5-7,9,11,17-21H2,1-4H3,(H,44,45) SNUPARNCTJQMEM-UHFFFAOYSA-N 571510 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(3-hydroxy-3-methylbutyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 74 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 19600 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571510&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591959 473132655 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206854 CCc1c-2c(nn1C)C(CCC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClFN3O5/c1-5-29-33-32-28(39)16-15-27-26(11-9-21-47-30-12-8-10-23-22-24(40)13-14-25(23)30)36(37(44)45)43(35(27)32)19-6-7-20-48-31(17-18-38(2,3)46)34(33)41-42(29)4/h8,10,12-16,22,31,46H,5-7,9,11,17-21H2,1-4H3,(H,44,45) SNUPARNCTJQMEM-UHFFFAOYSA-N 571510 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-(3-hydroxy-3-methylbutyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 74 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 13300 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571510&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591959 473132655 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206855 CCc1c-2c(nn1C)C(CCC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClFN3O5/c1-5-29-33-32-28(39)16-15-27-26(11-9-21-47-30-12-8-10-23-22-24(40)13-14-25(23)30)36(37(44)45)43(35(27)32)19-6-7-20-48-31(17-18-38(2,3)46)34(33)41-42(29)4/h8,10,12-16,22,31,46H,5-7,9,11,17-21H2,1-4H3,(H,44,45) SNUPARNCTJQMEM-UHFFFAOYSA-N 571511 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(3-hydroxy-3-methylbutyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 75 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.370 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571511&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591959 473132656 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206856 CCc1c-2c(nn1C)C(CCC(C)(C)O)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H43ClFN3O5/c1-5-29-33-32-28(39)16-15-27-26(11-9-21-47-30-12-8-10-23-22-24(40)13-14-25(23)30)36(37(44)45)43(35(27)32)19-6-7-20-48-31(17-18-38(2,3)46)34(33)41-42(29)4/h8,10,12-16,22,31,46H,5-7,9,11,17-21H2,1-4H3,(H,44,45) SNUPARNCTJQMEM-UHFFFAOYSA-N 571512 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-15-(3-hydroxy-3-methylbutyl)-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 76 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 90.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571512&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591959 473132657 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206857 CCc1c-2c(nn1C)C(CCN1CC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H40ClF3N4O4/c1-3-29-33-32-28(39)14-13-27-26(9-7-19-49-30-10-6-8-23-20-24(40)11-12-25(23)30)36(37(47)48)46(35(27)32)16-4-5-18-50-31(34(33)43-44(29)2)15-17-45-21-38(41,42)22-45/h6,8,10-14,20,31H,3-5,7,9,15-19,21-22H2,1-2H3,(H,47,48) JZYOIBXKSDWGOE-UHFFFAOYSA-N 571513 (rac)-4-chloro-(15-rac)-[2-(3,3-difluoroazetidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 77 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.70 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571513&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591849 473132658 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206858 CCc1c-2c(nn1C)C(CCN1CC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H40ClF3N4O4/c1-3-29-33-32-28(39)14-13-27-26(9-7-19-49-30-10-6-8-23-20-24(40)11-12-25(23)30)36(37(47)48)46(35(27)32)16-4-5-18-50-31(34(33)43-44(29)2)15-17-45-21-38(41,42)22-45/h6,8,10-14,20,31H,3-5,7,9,15-19,21-22H2,1-2H3,(H,47,48) JZYOIBXKSDWGOE-UHFFFAOYSA-N 571514 (+)-4-chloro-15-[2-(3,3-difluoroazetidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 1)::US11440923, Example 78 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.420 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571514&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591849 473132659 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206859 CCc1c-2c(nn1C)C(CCN1CC(F)(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H40ClF3N4O4/c1-3-29-33-32-28(39)14-13-27-26(9-7-19-49-30-10-6-8-23-20-24(40)11-12-25(23)30)36(37(47)48)46(35(27)32)16-4-5-18-50-31(34(33)43-44(29)2)15-17-45-21-38(41,42)22-45/h6,8,10-14,20,31H,3-5,7,9,15-19,21-22H2,1-2H3,(H,47,48) JZYOIBXKSDWGOE-UHFFFAOYSA-N 571515 (−)-4-chloro-15-[2-(3,3-difluoroazetidin-1-yl)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid—N-ethylethanamine Salt (Enantiomer 2)::US11440923, Example 79 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 14.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571515&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591849 473132660 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206860 CCc1c-2c(nn1C)C(CCN(C)OC)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H42ClFN4O5/c1-5-29-33-32-28(38)16-15-27-26(11-9-21-47-30-12-8-10-23-22-24(39)13-14-25(23)30)36(37(44)45)43(35(27)32)18-6-7-20-48-31(17-19-41(2)46-4)34(33)40-42(29)3/h8,10,12-16,22,31H,5-7,9,11,17-21H2,1-4H3,(H,44,45) RBVKBBSZJHQGPO-UHFFFAOYSA-N 571516 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-(15-rac)-{2-[methoxy(methyl)amino]ethyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 80 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.50 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571516&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591890 473132661 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206861 CCc1c-2c(nn1C)C(CCN(C)C)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H42ClFN4O4/c1-5-29-33-32-28(38)16-15-27-26(11-9-21-46-30-12-8-10-23-22-24(39)13-14-25(23)30)36(37(44)45)43(35(27)32)18-6-7-20-47-31(17-19-41(2)3)34(33)40-42(29)4/h8,10,12-16,22,31H,5-7,9,11,17-21H2,1-4H3,(H,44,45) IDDPEDPZMHSKMH-UHFFFAOYSA-N 571517 4-chloro-15-[2-(dimethylamino)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Stereoisomer 1)::US11440923, Example 82::US11440923, Example 83::US11440923, Example 84::US11440923, Example 85 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 42.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571517&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 155123493 473132662 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206862 CCc1c-2c(nn1C)C(CCN(C)C)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H42ClFN4O4/c1-5-29-33-32-28(38)16-15-27-26(11-9-21-46-30-12-8-10-23-22-24(39)13-14-25(23)30)36(37(44)45)43(35(27)32)18-6-7-20-47-31(17-19-41(2)3)34(33)40-42(29)4/h8,10,12-16,22,31H,5-7,9,11,17-21H2,1-4H3,(H,44,45) IDDPEDPZMHSKMH-UHFFFAOYSA-N 571517 4-chloro-15-[2-(dimethylamino)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Stereoisomer 1)::US11440923, Example 82::US11440923, Example 83::US11440923, Example 84::US11440923, Example 85 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571517&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 155123493 473132662 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206863 CCc1c-2c(nn1C)C(CCN(C)C)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H42ClFN4O4/c1-5-29-33-32-28(38)16-15-27-26(11-9-21-46-30-12-8-10-23-22-24(39)13-14-25(23)30)36(37(44)45)43(35(27)32)18-6-7-20-47-31(17-19-41(2)3)34(33)40-42(29)4/h8,10,12-16,22,31H,5-7,9,11,17-21H2,1-4H3,(H,44,45) IDDPEDPZMHSKMH-UHFFFAOYSA-N 571517 4-chloro-15-[2-(dimethylamino)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Stereoisomer 1)::US11440923, Example 82::US11440923, Example 83::US11440923, Example 84::US11440923, Example 85 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 16.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571517&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 155123493 473132662 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206864 CCc1c-2c(nn1C)C(CCN(C)C)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H42ClFN4O4/c1-5-29-33-32-28(38)16-15-27-26(11-9-21-46-30-12-8-10-23-22-24(39)13-14-25(23)30)36(37(44)45)43(35(27)32)18-6-7-20-47-31(17-19-41(2)3)34(33)40-42(29)4/h8,10,12-16,22,31H,5-7,9,11,17-21H2,1-4H3,(H,44,45) IDDPEDPZMHSKMH-UHFFFAOYSA-N 571517 4-chloro-15-[2-(dimethylamino)ethyl]-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Stereoisomer 1)::US11440923, Example 82::US11440923, Example 83::US11440923, Example 84::US11440923, Example 85 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.90 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571517&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 155123493 473132662 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206865 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCC(F)(F)CCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O5/c1-3-30-34-33-29(40)12-11-28-27(7-5-19-51-31-8-4-6-24-22-25(41)9-10-26(24)31)37(38(48)49)47(36(28)33)16-14-39(42,43)23-52-32(35(34)44-45(30)2)13-15-46-17-20-50-21-18-46/h4,6,8-12,22,32H,3,5,7,13-21,23H2,1-2H3,(H,48,49) DLLSKPFENYULCW-UHFFFAOYSA-N 571521 4-chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers 1)::US11440923, Example 86 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.60 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571521 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571521&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591950 473132663 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206866 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCC(F)(F)CCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O5/c1-3-30-34-33-29(40)12-11-28-27(7-5-19-51-31-8-4-6-24-22-25(41)9-10-26(24)31)37(38(48)49)47(36(28)33)16-14-39(42,43)23-52-32(35(34)44-45(30)2)13-15-46-17-20-50-21-18-46/h4,6,8-12,22,32H,3,5,7,13-21,23H2,1-2H3,(H,48,49) DLLSKPFENYULCW-UHFFFAOYSA-N 571522 (+)-4-chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11440923, Example 87 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.530 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571522 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571522&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591950 473132664 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206867 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCC(F)(F)CCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O5/c1-3-30-34-33-29(40)12-11-28-27(7-5-19-51-31-8-4-6-24-22-25(41)9-10-26(24)31)37(38(48)49)47(36(28)33)16-14-39(42,43)23-52-32(35(34)44-45(30)2)13-15-46-17-20-50-21-18-46/h4,6,8-12,22,32H,3,5,7,13-21,23H2,1-2H3,(H,48,49) DLLSKPFENYULCW-UHFFFAOYSA-N 571523 (−)-4-chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11440923, Example 88 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 17.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571523 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571523&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591950 473132665 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206868 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCC(F)(F)CCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O5/c1-3-30-34-33-29(40)12-11-28-27(7-5-19-51-31-8-4-6-24-22-25(41)9-10-26(24)31)37(38(48)49)47(36(28)33)16-14-39(42,43)23-52-32(35(34)44-45(30)2)13-15-46-17-20-50-21-18-46/h4,6,8-12,22,32H,3,5,7,13-21,23H2,1-2H3,(H,48,49) DLLSKPFENYULCW-UHFFFAOYSA-N 571524 4-chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Mixture of Stereoisomers 2)::US11440923, Example 89 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.00 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571524 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571524&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591950 473132666 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206869 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCC(F)(F)CCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O5/c1-3-30-34-33-29(40)12-11-28-27(7-5-19-51-31-8-4-6-24-22-25(41)9-10-26(24)31)37(38(48)49)47(36(28)33)16-14-39(42,43)23-52-32(35(34)44-45(30)2)13-15-46-17-20-50-21-18-46/h4,6,8-12,22,32H,3,5,7,13-21,23H2,1-2H3,(H,48,49) DLLSKPFENYULCW-UHFFFAOYSA-N 571525 (+)-4-chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 3)::US11440923, Example 90 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.460 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571525&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591950 473132667 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206870 CCc1c-2c(nn1C)C(CCN1CCOCC1)OCC(F)(F)CCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H42ClF3N4O5/c1-3-30-34-33-29(40)12-11-28-27(7-5-19-51-31-8-4-6-24-22-25(41)9-10-26(24)31)37(38(48)49)47(36(28)33)16-14-39(42,43)23-52-32(35(34)44-45(30)2)13-15-46-17-20-50-21-18-46/h4,6,8-12,22,32H,3,5,7,13-21,23H2,1-2H3,(H,48,49) DLLSKPFENYULCW-UHFFFAOYSA-N 571526 (−)-4-chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 4)::US11440923, Example 91 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 20.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571526 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571526&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591950 473132668 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206871 CCc1c-2c(nn1C)C(Cc1ccccc1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H39ClFN3O4/c1-3-32-36-35-31(41)19-18-30-29(14-10-22-48-33-15-9-13-26-24-27(42)16-17-28(26)33)39(40(46)47)45(38(30)35)20-7-8-21-49-34(37(36)43-44(32)2)23-25-11-5-4-6-12-25/h4-6,9,11-13,15-19,24,34H,3,7-8,10,14,20-23H2,1-2H3,(H,46,47) MPYDWEGXMHLZSW-UHFFFAOYSA-N 571527 (rac)-(rac-15)-benzyl-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 92 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.20 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571527 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571527&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591940 473132669 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206872 CCc1c-2c(nn1C)C(Cc1ccccc1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H39ClFN3O4/c1-3-32-36-35-31(41)19-18-30-29(14-10-22-48-33-15-9-13-26-24-27(42)16-17-28(26)33)39(40(46)47)45(38(30)35)20-7-8-21-49-34(37(36)43-44(32)2)23-25-11-5-4-6-12-25/h4-6,9,11-13,15-19,24,34H,3,7-8,10,14,20-23H2,1-2H3,(H,46,47) MPYDWEGXMHLZSW-UHFFFAOYSA-N 571527 (rac)-(rac-15)-benzyl-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 92 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 12200 US Patent 10.7270/Q2J38WT5 aid1806813 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571527 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571527&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591940 473132669 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206873 CCc1c-2c(nn1C)C(Cc1ccccc1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H39ClFN3O4/c1-3-32-36-35-31(41)19-18-30-29(14-10-22-48-33-15-9-13-26-24-27(42)16-17-28(26)33)39(40(46)47)45(38(30)35)20-7-8-21-49-34(37(36)43-44(32)2)23-25-11-5-4-6-12-25/h4-6,9,11-13,15-19,24,34H,3,7-8,10,14,20-23H2,1-2H3,(H,46,47) MPYDWEGXMHLZSW-UHFFFAOYSA-N 571527 (rac)-(rac-15)-benzyl-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 92 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 13200 US Patent 10.7270/Q2J38WT5 aid1806814 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571527 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571527&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591940 473132669 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1206874 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-22-51-34-11-7-9-26-25-27(42)12-13-28(26)34)39(40(48)49)47(38(30)35)18-6-5-17-44(2)33(37(36)43-45(32)3)16-19-46-20-23-50-24-21-46/h7,9,11-15,25,33H,4-6,8,10,16-24H2,1-3H3,(H,48,49) DKEGORYWTLFZBI-UHFFFAOYSA-N 571528 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid—Racemate 1::US11440923, Example 101::US11440923, Example 93::US11440923, Example 94::US11440923, Example 95::US11440923, Example 96::US11440923, Example 97::US11440923, Example 98 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571528&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591973 473132670 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206875 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-22-51-34-11-7-9-26-25-27(42)12-13-28(26)34)39(40(48)49)47(38(30)35)18-6-5-17-44(2)33(37(36)43-45(32)3)16-19-46-20-23-50-24-21-46/h7,9,11-15,25,33H,4-6,8,10,16-24H2,1-3H3,(H,48,49) DKEGORYWTLFZBI-UHFFFAOYSA-N 571528 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid—Racemate 1::US11440923, Example 101::US11440923, Example 93::US11440923, Example 94::US11440923, Example 95::US11440923, Example 96::US11440923, Example 97::US11440923, Example 98 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.640 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571528&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591973 473132670 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206876 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-22-51-34-11-7-9-26-25-27(42)12-13-28(26)34)39(40(48)49)47(38(30)35)18-6-5-17-44(2)33(37(36)43-45(32)3)16-19-46-20-23-50-24-21-46/h7,9,11-15,25,33H,4-6,8,10,16-24H2,1-3H3,(H,48,49) DKEGORYWTLFZBI-UHFFFAOYSA-N 571528 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid—Racemate 1::US11440923, Example 101::US11440923, Example 93::US11440923, Example 94::US11440923, Example 95::US11440923, Example 96::US11440923, Example 97::US11440923, Example 98 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 34.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571528&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591973 473132670 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206877 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-22-51-34-11-7-9-26-25-27(42)12-13-28(26)34)39(40(48)49)47(38(30)35)18-6-5-17-44(2)33(37(36)43-45(32)3)16-19-46-20-23-50-24-21-46/h7,9,11-15,25,33H,4-6,8,10,16-24H2,1-3H3,(H,48,49) DKEGORYWTLFZBI-UHFFFAOYSA-N 571528 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid—Racemate 1::US11440923, Example 101::US11440923, Example 93::US11440923, Example 94::US11440923, Example 95::US11440923, Example 96::US11440923, Example 97::US11440923, Example 98 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.950 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571528&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591973 473132670 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206878 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-22-51-34-11-7-9-26-25-27(42)12-13-28(26)34)39(40(48)49)47(38(30)35)18-6-5-17-44(2)33(37(36)43-45(32)3)16-19-46-20-23-50-24-21-46/h7,9,11-15,25,33H,4-6,8,10,16-24H2,1-3H3,(H,48,49) DKEGORYWTLFZBI-UHFFFAOYSA-N 571528 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid—Racemate 1::US11440923, Example 101::US11440923, Example 93::US11440923, Example 94::US11440923, Example 95::US11440923, Example 96::US11440923, Example 97::US11440923, Example 98 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.600 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571528&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591973 473132670 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206879 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-22-51-34-11-7-9-26-25-27(42)12-13-28(26)34)39(40(48)49)47(38(30)35)18-6-5-17-44(2)33(37(36)43-45(32)3)16-19-46-20-23-50-24-21-46/h7,9,11-15,25,33H,4-6,8,10,16-24H2,1-3H3,(H,48,49) DKEGORYWTLFZBI-UHFFFAOYSA-N 571528 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid—Racemate 1::US11440923, Example 101::US11440923, Example 93::US11440923, Example 94::US11440923, Example 95::US11440923, Example 96::US11440923, Example 97::US11440923, Example 98 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 32.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571528&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591973 473132670 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206880 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)CCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H48ClN5O4/c1-4-32-36-35-31(41)17-16-30-29(14-10-24-50-34-15-9-12-27-11-5-6-13-28(27)34)39(40(47)48)46(38(30)35)20-8-7-19-43(2)33(37(36)42-44(32)3)18-21-45-22-25-49-26-23-45/h5-6,9,11-13,15-17,33H,4,7-8,10,14,18-26H2,1-3H3,(H,47,48) VSCAQHKPSYCRGF-UHFFFAOYSA-N 571534 (rac)-4-chloro-3-ethyl-2,14-dimethyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic::US11440923, Example 100::US11440923, Example 99 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571534&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591966 473132671 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206881 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)CCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H48ClN5O4/c1-4-32-36-35-31(41)17-16-30-29(14-10-24-50-34-15-9-12-27-11-5-6-13-28(27)34)39(40(47)48)46(38(30)35)20-8-7-19-43(2)33(37(36)42-44(32)3)18-21-45-22-25-49-26-23-45/h5-6,9,11-13,15-17,33H,4,7-8,10,14,18-26H2,1-3H3,(H,47,48) VSCAQHKPSYCRGF-UHFFFAOYSA-N 571534 (rac)-4-chloro-3-ethyl-2,14-dimethyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic::US11440923, Example 100::US11440923, Example 99 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.60 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571534&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591966 473132671 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206882 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H47ClFN5O4/c1-4-32-36-35-31(41)15-14-30-29(10-8-22-51-34-11-7-9-26-25-27(42)12-13-28(26)34)39(40(48)49)47(38(30)35)18-6-5-17-44(2)33(37(36)43-45(32)3)16-19-46-20-23-50-24-21-46/h7,9,11-15,25,33H,4-6,8,10,16-24H2,1-3H3,(H,48,49) DKEGORYWTLFZBI-UHFFFAOYSA-N 571528 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-(15-rac)-[2-(morpholin-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid—Racemate 1::US11440923, Example 101::US11440923, Example 93::US11440923, Example 94::US11440923, Example 95::US11440923, Example 96::US11440923, Example 97::US11440923, Example 98 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.80 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571528&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591973 473132670 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206883 CCc1c-2c(nn1C)C1CCCCN1CCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClN4O3/c1-3-29-33-32-28(38)19-18-27-26(15-11-23-45-31-17-10-13-24-12-4-5-14-25(24)31)36(37(43)44)42(35(27)32)22-9-8-21-41-20-7-6-16-30(41)34(33)39-40(29)2/h4-5,10,12-14,17-19,30H,3,6-9,11,15-16,20-23H2,1-2H3,(H,43,44) AOBVUBMWZIKPMN-UHFFFAOYSA-N 571537 (rac)-18-chloro-1-ethyl-2-methyl-15-[3-(1-naphthyloxy)propyl]-2,3b,4,5,6,7,9,10,11,12-decahydropyrazolo[3′,4′:8,9]pyrido[1′,2′:6,7][1,6]diazacycloundecino[10,11,1-hi]indole-14-carboxylic Acid (Isomer 1)::US11440923, Example 102::US11440923, Example 103 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.40 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571537 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571537&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591835 473132672 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206884 CCc1c-2c(nn1C)C1CCCCN1CCCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c-2c13 InChI=1S/C37H41ClN4O3/c1-3-29-33-32-28(38)19-18-27-26(15-11-23-45-31-17-10-13-24-12-4-5-14-25(24)31)36(37(43)44)42(35(27)32)22-9-8-21-41-20-7-6-16-30(41)34(33)39-40(29)2/h4-5,10,12-14,17-19,30H,3,6-9,11,15-16,20-23H2,1-2H3,(H,43,44) AOBVUBMWZIKPMN-UHFFFAOYSA-N 571537 (rac)-18-chloro-1-ethyl-2-methyl-15-[3-(1-naphthyloxy)propyl]-2,3b,4,5,6,7,9,10,11,12-decahydropyrazolo[3′,4′:8,9]pyrido[1′,2′:6,7][1,6]diazacycloundecino[10,11,1-hi]indole-14-carboxylic Acid (Isomer 1)::US11440923, Example 102::US11440923, Example 103 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.940 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571537 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571537&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591835 473132672 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206885 CCc1c-2c(nn1C)C1CCCN1CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H38ClFN4O3/c1-3-28-32-31-27(37)16-15-26-25(10-8-20-45-30-12-6-9-22-21-23(38)13-14-24(22)30)35(36(43)44)42(34(26)31)19-5-4-17-41-18-7-11-29(41)33(32)39-40(28)2/h6,9,12-16,21,29H,3-5,7-8,10-11,17-20H2,1-2H3,(H,43,44) AGLLPJYSQPPHJN-UHFFFAOYSA-N 571539 (rac)-17-chloro-1-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-3b,4,5,6,8,9,10,11-octahydro-2H-pyrazolo[3′,4′:8,9]pyrrolo[1′,2′:6,7][1,6]diazacycloundecino[10,11,1-hi]indole-13-carboxylic Acid (Isomer 1, Diasteromer of Example 107)::US11440923, Example 104 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.880 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571539&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591828 473132673 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206886 CCc1c-2c(nn1C)C1CCCN1CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H38ClFN4O3/c1-3-28-32-31-27(37)16-15-26-25(10-8-20-45-30-12-6-9-22-21-23(38)13-14-24(22)30)35(36(43)44)42(34(26)31)19-5-4-17-41-18-7-11-29(41)33(32)39-40(28)2/h6,9,12-16,21,29H,3-5,7-8,10-11,17-20H2,1-2H3,(H,43,44) AGLLPJYSQPPHJN-UHFFFAOYSA-N 571540 (+)-17-chloro-1-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-3b,4,5,6,8,9,10,11-octahydro-2H-pyrazolo[3′,4′:8,9]pyrrolo[1′,2′:6,7][1,6]diazacycloundecino[10,11,1-hi]indole-13-carboxylic Acid (Enantiomer 1)::US11440923, Example 105 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571540&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591828 473132674 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206887 CCc1c-2c(nn1C)C1CCCN1CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H38ClFN4O3/c1-3-28-32-31-27(37)16-15-26-25(10-8-20-45-30-12-6-9-22-21-23(38)13-14-24(22)30)35(36(43)44)42(34(26)31)19-5-4-17-41-18-7-11-29(41)33(32)39-40(28)2/h6,9,12-16,21,29H,3-5,7-8,10-11,17-20H2,1-2H3,(H,43,44) AGLLPJYSQPPHJN-UHFFFAOYSA-N 571541 (−)-17-chloro-1-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-3b,4,5,6,8,9,10,11-octahydro-2H-pyrazolo[3′,4′:8,9]pyrrolo[1′,2′:6,7][1,6]diazacycloundecino[10,11,1-hi]indole-13-carboxylic Acid (Enantiomer 2)::US11440923, Example 106 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 17.0 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571541&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591828 473132675 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206888 CCc1c-2c(nn1C)C1CCCN1CCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C36H38ClFN4O3/c1-3-28-32-31-27(37)16-15-26-25(10-8-20-45-30-12-6-9-22-21-23(38)13-14-24(22)30)35(36(43)44)42(34(26)31)19-5-4-17-41-18-7-11-29(41)33(32)39-40(28)2/h6,9,12-16,21,29H,3-5,7-8,10-11,17-20H2,1-2H3,(H,43,44) AGLLPJYSQPPHJN-UHFFFAOYSA-N 571542 (rac)-17-chloro-1-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-3b,4,5,6,8,9,10,11-octahydro-2H-pyrazolo[3′,4′:8,9]pyrrolo[1′,2′:6,7][1,6]diazacycloundecino[10,11,1-hi]indole-13-carboxylic Acid (Isomer 2, Diastereomer of Example 104)::US11440923, Example 107 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571542&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591828 473132676 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1206889 CCc1c-2c(nn1C)C(CCN1CC(F)C1)OCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C38H41ClF2N4O4/c1-3-30-34-33-29(39)14-13-28-27(9-7-19-48-31-10-6-8-23-20-24(40)11-12-26(23)31)37(38(46)47)45(36(28)33)16-4-5-18-49-32(35(34)42-43(30)2)15-17-44-21-25(41)22-44/h6,8,10-14,20,25,32H,3-5,7,9,15-19,21-22H2,1-2H3,(H,46,47) SOTBKPIWLHXQGJ-UHFFFAOYSA-N 571543 (rac)-4-chloro-3-ethyl-15-[2-(rac)-(3-fluoroazetidin-1-yl)ethyl]-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11440923, Example 108 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2J38WT5 aid1806812 US11440923 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K; Wittrock, S; McKinney, D; Serrano-Wu, MH; Lemke, C; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA 9/13/2022 11/19/2022 TBA http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571543&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591838 473132677 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589